Other or unspecified ileus, impaction or obstruction

K11_OTHILEUS

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — K56.4, K56.6, K56.7 Hospital discharge: ICD-9 — 5608\|5609 Hospital discharge: ICD-8 — 5609 Hospital discharge: excluded ICD-9 — 5608A Cause of death: ICD-10 — K56.4, K56.6, K56.7 Cause of death: ICD-9 — 5608\|5609 Cause of death: ICD-8 — 5609 Cause of death: excluded ICD-9 — 5608A 2 out of 7 registries used, show all original rules.	8280
4. Check minimum number of events None	8280
5. Include endpoints None	8280
6. Filter based on genotype QC (FinnGen only)	8280

Control definitions (FinnGen only)

Control exclude: K11_INTESTOTH

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2

NAME	K11_OTHILEUS
CONTROL_EXCLUDE	K11_INTESTOTH
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K564\|K56[6-7]
HD_ICD_9	5608\|5609
HD_ICD_8	5609
HD_ICD_10_EXCL
HD_ICD_9_EXCL	5608A
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	K564\|K56[6-7]
COD_ICD_9	5608\|5609
COD_ICD_8	5609
COD_ICD_10_EXCL
COD_ICD_9_EXCL	5608A
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other or unspecified ileus, impaction or obstruction based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	77370	39030	37319
Only index persons	56491	28754	27737
Unadjusted period prevalence (%)
Whole population	1.08	1.12	1.04
Only index persons	1.06	1.06	1.06
Median age at first event (years)
Whole population	68.71	70.35	66.98
Only index persons	66.98	68.35	65.57

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	8280	3768	4512
Unadjusted period prevalence (%)	1.67	1.28	1.99
Median age at first event (years)	64.25	61.50	66.54

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
7377: Matched controls
73743

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

JN3AD

NOMESCO Finland

Abdominal CT examination

10.0

323.0

1539

1901

JAH00

NOMESCO Finland

Laparotomy

30.7

323.0

1136

435

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

9439.2

323.0

5127

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

30.8

323.0

571

200

JFB00

NOMESCO Finland

Partial resection of small intestine

66.8

323.0

843

142

K56.7

ICD-10 Finland

Ileus, unspecified

4306.8

323.0

2240

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

19.9

323.0

1402

857

JN3BD

NOMESCO Finland

Extensive abdominal CT

11.6

323.0

2261

2703

WX302

NOMESCO Finland

Thoracal epidural anesthesy

10.0

323.0

1187

1384

UJF32

NOMESCO Finland

Coloscopy

7.3

323.0

3044

6455

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.5

323.0

2777

10968

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

5.7

323.0

3898

12078

K56.0

ICD-10 Finland

Paralytic ileus

5662.8

323.0

537

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

7967.5

323.0

1336

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

9.1

323.0

1295

1685

A03FA01

ATC

metoclopramide; systemic, rectal

3.3

323.0

2206

8473

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

65.8

323.0

504

K59.0

ICD-10 Finland

Constipation

10.1

323.0

748

813

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

17.9

323.0

1465

1007

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

114.5

323.0

1001

101

K59.09

ICD-10 Finland

Constipation, unspecified

15.4

323.0

856

621

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

8.5

323.0

801

1043

WX408

NOMESCO Finland

General anesthesy, balanced

2.9

320.4

2531

11182

A06AD11

ATC

lactulose; oral

3.5

318.8

1746

5932

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

5.4

311.7

1029

2151

5609X

ICD-9 Finland

Intestinal obstruction without mention of hernia, Unspecified intestinal obstruction

+∞

311.6

297

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

9.1

303.9

676

811

130

Kela drug reimbursment

Malignant tumour

4.2

293.6

1268

3487

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

3.5

292.9

1584

5285

P01AB01

ATC

metronidazole; oral, rectal

2.6

288.0

2937

14914

K56.2

ICD-10 Finland

Volvulus

2746.5

285.9

275

JFK10

NOMESCO Finland

Freeing of adhesions in intestinal obstruction

485.9

284.1

282

TPH04

NOMESCO Finland

Cathetrisation of vein

2.9

278.8

2068

8619

L01BC06

ATC

capecitabine; oral

7.4

266.3

675

991

UJF30

NOMESCO Finland

Ileoscopy through colon

5.7

261.3

809

1551

56096

ICD-8 Finland

Intestinal obstruction without mention of hernia, Ileus propter adhaesionem (functione laesa circulationis intestinalis non indicata)

+∞

258.8

247

JAH01

NOMESCO Finland

Laparoscopy

7.8

255.5

623

861

K50.0

ICD-10 Finland

Crohn disease of small intestine

26.4

250.1

353

140

JN4BD

NOMESCO Finland

Extensive body CT

3.5

247.2

1308

4231

R11

ICD-10 Finland

Nausea and vomiting

4.6

245.9

948

2309

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

5.1

244.7

833

1778

N02AA05

ATC

oxycodone; systemic

3.0

241.3

1646

6400

A07EC02

ATC

mesalazine; oral, rectal

6.6

239.3

659

1083

TPH07

NOMESCO Finland

Cathetrisation of artery

3.6

236.2

1216

3836

A06AC01

ATC

ispaghula (psylla seeds); oral

2.8

235.8

1873

8017

B01AB05

ATC

enoxaparin; parenteral

2.4

234.2

2688

14138

A02BC02

ATC

pantoprazole; systemic

2.3

232.8

4867

34038

JFF10

NOMESCO Finland

Loop enterostomy

51.2

224.3

272

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

3.1

221.2

1421

5266

K50.8

ICD-10 Finland

Other Crohn disease

22.7

220.8

326

150

K50.9

ICD-10 Finland

Crohn disease, unspecified

21.6

219.4

329

159

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

728.9

216.9

213

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.2

211.8

1292

4603

J01MA02

ATC

ciprofloxacin; systemic

2.2

204.8

3172

18921

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

13.7

203.5

363

278

N02AX02

ATC

tramadol; systemic, rectal

2.2

203.3

3347

20493

JFB30

NOMESCO Finland

Right hemicolectomy

13.0

203.0

371

300

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

7.7

202.1

495

683

R10.0

ICD-10 Finland

Acute abdomen

8.7

201.9

457

556

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.1

195.8

3522

22278

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

8.4

195.8

452

568

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.7

192.6

1557

6623

JFK00

NOMESCO Finland

Division of adhesive band in intestinal obstruction

946.8

189.4

185

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

32.0

185.2

248

JFB46

NOMESCO Finland

Resection of sigmoid colon

22.4

177.1

262

121

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

8.6

176.7

402

492

L04AX01

ATC

azathioprine; systemic

5.7

175.2

539

1010

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

3.2

173.0

1018

3493

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

40.6

171.1

217

A07EA06

ATC

budesonide; oral, local oral

8.0

169.1

403

531

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.8

167.7

1265

5111

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.3

167.6

944

3131

N02BE01

ATC

paracetamol; systemic, rectal

2.3

166.2

6188

51123

K57.2

ICD-10 Finland

Diverticular disease of large intestine with perforation and abscess

89.8

164.9

184

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

113.3

162.8

177

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

4.8

162.2

583

1299

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

47.0

160.0

197

JN4AD

NOMESCO Finland

Body CT examination

3.4

157.5

844

2690

D01

ICPC

Abdominal pain/cramps general

3.6

157.3

786

2371

K51.5

ICD-10 Finland

Left sided colitis

8.3

156.7

362

453

JFF23

NOMESCO Finland

Transversostomy

15.8

155.4

260

170

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.8

155.0

1121

4394

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

7.8

154.9

374

502

K50.1

ICD-10 Finland

Crohn disease of large intestine

21.0

153.6

232

114

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

8.7

153.4

344

410

ZX120

NOMESCO Finland

Intravenous

3.1

153.1

939

3300

45599

ICD-8 Finland

Haemorrhoids

+∞

152.6

146

B01AB10

ATC

tinzaparin; parenteral

3.6

150.3

749

2250

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

16.2

147.9

245

156

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

5.7

147.3

447

820

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

13.9

145.2

256

190

Z93.3

ICD-10 Finland

Colostomy status

23.3

144.6

211

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

52.3

144.2

174

Z51.5

ICD-10 Finland

Palliative care

3.5

144.1

752

2340

JF1BD

NOMESCO Finland

Very extensive small bowel CT

36.6

143.6

186

J01MA12

ATC

levofloxacin; systemic

2.3

142.6

1621

8099

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.3

142.1

1517

7351

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

5.1

140.1

472

977

56099

ICD-8 Finland

Intestinal obstruction without mention of hernia, Other and unspecified

+∞

138.9

133

JFB20

NOMESCO Finland

Ileocaecal resection

39.2

137.9

176

A04AA01

ATC

ondansetron; systemic, rectal

3.6

136.8

682

2043

TJF80

NOMESCO Finland

Ostomy education

15.4

135.6

229

153

A04AA02

ATC

granisetron; systemic, transdermal

3.6

135.5

671

1999

JFB60

NOMESCO Finland

Resection of sigmoid colon with end colostomy

63.7

133.6

156

WX402

NOMESCO Finland

General anaesthesia

2.4

131.2

1249

5681

N03AX16

ATC

pregabalin; oral

2.1

131.1

1734

9234

C10AC01

ATC

colestyramine; oral

7.9

129.8

309

405

H02AB02

ATC

dexamethasone; systemic

2.7

129.7

994

4005

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

2.0

128.8

2312

13920

K57.9

ICD-10 Finland

Diverticular disease of intestine, part unspecified, without perforation or abscess

34.8

127.5

167

UJG02

NOMESCO Finland

Proctoscopy

9.3

123.3

266

296

JEA00

NOMESCO Finland

Appendectomy

3.8

122.3

568

1600

Z93.2

ICD-10 Finland

Ileostomy status

45.2

122.0

151

JF1AD

NOMESCO Finland

Small bowel CT

30.8

120.9

163

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

3.8

119.4

555

1564

K55.0

ICD-10 Finland

Acute vascular disorders of intestine

+∞

119.0

114

5608A

ICD-9 Finland

Intestinal obstruction without mention of hernia, Other specified intestinal obstruction[OBSTRUCTIO INTESTINALIS ,ADHESIONES INTRAABDOMINALE]

+∞

119.0

114

J01DB01

ATC

cefalexin; oral

1.9

118.8

5536

45473

TPX10

NOMESCO Finland

Implantation of vascular injection port

5.4

118.5

379

738

JWA00

NOMESCO Finland

Repair of wound dehiscence in gastroenterological surgery

28.8

117.4

161

R50.9

ICD-10 Finland

Fever, unspecified

2.4

113.9

1115

5114

JFA70

NOMESCO Finland

Suture of small intestine

59.3

113.6

134

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

8.2

113.3

264

334

56095

ICD-8 Finland

Intestinal obstruction without mention of hernia, Ileus propter adhaesionem, cum functione laesa circulationis intestinalis

+∞

112.7

108

A02BC01

ATC

omeprazole; systemic

1.9

112.7

2095

12646

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.2

111.8

636

2095

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.0

111.6

712

2541

K60.3

ICD-10 Finland

Anal fistula

194.5

110.7

115

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

5.3

109.7

356

704

A07EA02

ATC

hydrocortisone; rectal

7.4

109.7

272

379

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

14.5

109.6

189

133

K92.1

ICD-10 Finland

Melaena

3.9

108.7

485

1317

K65.0

ICD-10 Finland

Acute peritonitis

11.3

107.9

209

190

SPAT1125

SPAT

Stoma care and guidance

7.5

107.6

264

362

K59.1

ICD-10 Finland

Functional diarrhoea

5.2

106.3

349

699

K51.8

ICD-10 Finland

Other ulcerative colitis

11.6

105.9

202

178

6453

FHL

Radical surgery of hemorrhoids

160.8

105.5

111

K56.4

ICD-10 Finland

Other impaction of intestine

1032.4

104.5

102

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.9

104.3

2076

12771

JFG40

NOMESCO Finland

Revision of enterostomy or colostomy without laparotomy

42.6

103.9

130

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.8

103.3

719

2710

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.3

101.1

1118

5415

K91.4

ICD-10 Finland

Colostomy and enterostomy malfunction

55.4

100.7

120

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

24.7

100.0

143

WW500

NOMESCO Finland

Blood transfusion

4.0

99.2

428

1127

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

4.2

99.0

396

972

B03BA03

ATC

hydroxocobalamin; parenteral

3.0

98.4

631

2253

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

16.7

98.1

160

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.3

97.6

1054

5040

A02BC05

ATC

esomeprazole; systemic

1.7

97.3

2682

18244

N05CF01

ATC

zopiclone; oral

1.8

96.1

2412

15925

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

12.7

95.7

175

141

JFH10

NOMESCO Finland

Total colectomy and ileostomy

59.8

95.2

112

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

94.3

2391

15810

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

4.0

93.0

391

1005

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

5.7

92.9

279

503

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

5.5

92.5

289

546

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.2

91.7

1095

5470

JFF13

NOMESCO Finland

Terminal enterostomy

70.8

91.5

105

JKA20

NOMESCO Finland

Cholecystectomy

4.4

91.5

349

818

Z98.0

ICD-10 Finland

Intestinal bypass and anastomosis status

29.7

90.7

123

SPAT1262

SPAT

Handing over of treatment supplies

2.0

90.2

1454

8214

JFA58

NOMESCO Finland

Endoscopic dilatation of colon

52.1

89.7

108

D64.9

ICD-10 Finland

Anaemia, unspecified

2.4

89.4

874

3970

128

Kela drug reimbursment

Cancers of female genital organs

6.9

89.3

233

349

H02AB06

ATC

prednisolone; systemic

1.7

88.4

3222

23552

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

6.9

87.7

228

340

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.0

87.4

1394

7832

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

7.6

87.3

212

286

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.7

87.0

413

1178

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

3.5

86.9

429

1263

JAL30

NOMESCO Finland

Omentectomy

9.3

86.2

185

204

K59.9

ICD-10 Finland

Functional intestinal disorder, unspecified

16.2

85.1

140

C03CA01

ATC

furosemide; systemic

1.7

84.6

2464

16847

WZC30

NOMESCO Finland

Teaching

2.2

84.3

997

4945

WX306

NOMESCO Finland

Lumbar epidural anesthesy

3.5

84.1

428

1291

A28

ICPC

Limited function/disability NOS

2.0

82.4

1277

7075

K61.0

ICD-10 Finland

Anal abscess

41.7

82.1

103

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

7.8

81.5

194

254

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.3

81.3

801

3641

R53

ICD-10 Finland

Malaise and fatigue

1.9

81.3

1427

8275

6561

FHL

Removal of fasteners and related measures

38.7

80.8

103

XF400

NOMESCO Finland

ECG with 12 standard connections

1.9

80.3

1312

7408

A02BC03

ATC

lansoprazole; oral

1.7

77.9

2020

13280

S18

ICPC

Laceration/cut

1.6

77.3

2825

20421

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

9.2

77.2

166

184

N06AX11

ATC

mirtazapine; oral

1.7

76.9

1999

13139

TKC20

NOMESCO Finland

Catheterisation of bladder

2.5

76.5

650

2731

K43.0

ICD-10 Finland

Incisional hernia with obstruction, without gangrene

9.8

76.5

159

166

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

4.4

74.6

283

659

UKC02

NOMESCO Finland

Cystoscopy

1.9

74.1

1277

7328

JFB43

NOMESCO Finland

Left hemicolectomy

13.9

73.9

129

UJF92

NOMESCO Finland

Capsular endoscopy

7.6

73.6

178

239

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.5

73.3

607

2515

K56.1

ICD-10 Finland

Intussusception

365.7

72.8

A41.9

ICD-10 Finland

Sepsis, unspecified

3.4

72.4

375

1144

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

3.7

72.4

338

949

JHA00

NOMESCO Finland

Anal or perianal incision

28.6

72.4

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.2

72.1

400

1285

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.0

71.7

1079

5880

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

5.2

71.5

231

454

WX892

NOMESCO Finland

Monitored bed care

2.5

71.4

624

2659

JFH00

NOMESCO Finland

Total colectomy and ileorectal anastomosis

44.4

71.2

WX002

NOMESCO Finland

Sedation and analgesia

1.8

70.9

1369

8158

JF1DG

NOMESCO Finland

Small bowel very extensive MRI with with high intensity magnet

59.9

70.7

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

2.9

70.2

454

1620

JFG20

NOMESCO Finland

Closure of enterostomy with resection of exteriorised loop

22.2

70.1

103

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

6.4

70.0

190

301

SPAT1254

SPAT

Administration of medicine

1.9

69.9

1106

6137

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

4.7

68.9

247

543

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

68.7

1174

6699

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

5.2

68.7

224

445

K59.01

ICD-10 Finland

Constipation outlet obstruction type

345.2

68.6

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.4

68.5

612

2638

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

5.9

68.4

198

341

A03FA02

ATC

cisapride; oral, rectal

2.4

68.2

615

2660

JAD10

NOMESCO Finland

Repair of incisional hernia

10.3

67.5

136

134

Z93

ICD-10 Finland

Artificial opening status

23.1

67.5

WX882

NOMESCO Finland

High dependency care

4.1

67.5

278

700

R4190

NOMESCO Finland

Nutritional therapy

4.1

67.5

274

681

N30.0

ICD-10 Finland

Acute cystitis

2.0

67.5

908

4726

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

4.6

67.4

246

551

D12

ICPC

Constipation

4.0

67.4

283

725

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

12.8

67.3

122

D99

ICPC

Disease digestive system other

8.8

67.3

148

171

A02BA02

ATC

ranitidine; systemic

1.8

66.8

1399

8544

N05BA04

ATC

oxazepam; oral

1.7

66.6

1617

10337

JGB00

NOMESCO Finland

Partial proctectomy and colorectal or coloanal anastomosis

13.3

66.3

118

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

6.9

66.1

170

250

A07DA03

ATC

loperamide; oral

3.5

65.8

330

982

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

6.4

65.7

180

289

JFC00

NOMESCO Finland

Entero-enterostomy

36.9

65.4

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

3.0

65.2

394

1343

R33

ICD-10 Finland

Retention of urine

2.3

65.1

689

3226

K91.2

ICD-10 Finland

Postsurgical malabsorption, not elsewhere classified

59.0

64.7

5608X

ICD-9 Finland

Intestinal obstruction without mention of hernia, Other specified intestinal obstruction[OBSTRUCTIO INTESTINALIS, MUU SYY]

+∞

64.6

SPAT1263

SPAT

Sampling

1.6

63.8

2710

20054

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

9.3

62.5

133

145

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

13.6

62.5

110

A09AA02

ATC

multienzymes (lipase, protease etc.)

4.7

62.3

222

485

UJH02

NOMESCO Finland

Anoscopy

4.3

62.3

243

581

SPAT1255

SPAT

Intravenous administration of medicine

2.5

61.8

519

2160

D94

ICPC

Chronic enteritis/ulcerative colitis

16.3

61.3

100

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

3.2

61.0

339

1090

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

3.0

60.8

374

1290

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

3.0

60.7

366

1245

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

9.4

60.6

128

138

K57.0

ICD-10 Finland

Diverticular disease of small intestine with perforation and abscess

310.0

60.4

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

8.1

59.5

138

174

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.2

59.4

654

3111

K63.2

ICD-10 Finland

Fistula of intestine

+∞

59.4

56098

ICD-8 Finland

Intestinal obstruction without mention of hernia, Alii definiti

+∞

59.4

B81

ICPC

Anaemia vit B12/folate deficiency

3.0

59.1

362

1244

K57.1

ICD-10 Finland

Diverticular disease of small intestine without perforation or abscess

26.7

59.0

WX704

NOMESCO Finland

Intubation

2.4

59.0

520

2219

N05AH04

ATC

quetiapine; oral

1.9

58.9

959

5352

LAF10

NOMESCO Finland

Bilateral salpingo-oophorectomy

3.7

58.7

273

764

N06AB04

ATC

citalopram; systemic

1.7

58.5

1351

8461

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

5.2

58.5

189

372

WX110

NOMESCO Finland

Local anesthesy

1.5

58.2

4142

34107

D18

ICPC

Change in faeces/bowel movements

5.3

58.1

183

350

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

7.0

58.0

147

212

N05BA01

ATC

diazepam; systemic, rectal

1.9

57.9

922

5100

C20

ICD-10 Finland

Malignant neoplasm of rectum

8.1

57.8

134

169

JFH30

NOMESCO Finland

Total colectomy, mucosal proctectomy and ileoanal anastomosis without ileostomy

40.4

57.2

K92.0

ICD-10 Finland

Haematemesis

3.9

56.9

247

652

ZXK00

NOMESCO Finland

Conversion from percutaneous endoscopic to open procedure

10.0

56.7

116

118

JGB30

NOMESCO Finland

Abdominoperineal excision of rectum

17.6

56.2

N05AA02

ATC

levomepromazine; systemic

3.1

56.1

334

1125

6402

FHL

Small bowel resection

32.5

56.1

UJD02

NOMESCO Finland

Gastroscopy

2.8

55.9

373

1354

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

4.2

55.8

224

551

N03AX12

ATC

gabapentin; oral

1.9

55.7

955

5421

D75

ICPC

Malignant neoplasm colon/rectum

9.1

55.5

119

132

K66.0

ICD-10 Finland

Peritoneal adhesions

20.4

55.2

JFB50

NOMESCO Finland

Other resection of colon

29.9

54.9

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.2

54.8

629

3045

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

54.3

2061

14702

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.4

54.2

273

815

K60.1

ICD-10 Finland

Chronic anal fissure

22.2

53.9

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.8

53.9

374

1390

N05CD07

ATC

temazepam; oral

1.8

53.9

994

5782

JF2AB

NOMESCO Finland

Colongraphy with X-ray

26.7

53.3

R06.0

ICD-10 Finland

Dyspnoea

1.6

53.2

1613

10867

D06

ICPC

Abdominal pain localized other

2.5

53.1

437

1794

E87.6

ICD-10 Finland

Hypokalaemia

3.4

52.9

273

830

N06AX21

ATC

duloxetine; oral

2.2

52.8

599

2885

E86

ICD-10 Finland

Volume depletion

3.6

52.6

252

723

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.4

52.5

458

1943

R4110

NOMESCO Finland

Physiotherapy

1.6

52.5

1721

11825

N06AA09

ATC

amitriptyline; systemic

2.1

52.4

667

3376

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

5.5

52.3

161

300

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

52.1

1294

8247

UJF02

NOMESCO Finland

Peroral enteroscopy

13.1

52.1

JFB33

NOMESCO Finland

Other resection comprising small intestine and colon

35.5

51.9

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

7.5

51.8

125

168

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.0

51.7

755

4035

K62.3

ICD-10 Finland

Rectal prolapse

32.6

51.7

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

9.1

51.6

111

124

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.4

51.5

483

2126

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

5.0

51.1

169

342

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.4

51.1

452

1931

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

3.4

50.9

260

785

J01DA01

ATC

[U] cefalexin; systemic

1.4

50.5

4018

33378

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

3.3

50.3

267

830

R18

ICD-10 Finland

Ascites

4.3

50.0

195

467

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

49.8

2937

22963

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.7

49.6

1074

6559

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.7

49.3

1157

7238

WF001

NOMESCO Finland

Preoperative radiotherapy

7.7

49.2

117

154

XF600

NOMESCO Finland

Bloodpressure measurement

2.3

48.5

468

2085

SPAT1301

SPAT

No procedures

1.5

48.4

2086

15235

SPAT1153

SPAT

Removal of sutures

1.5

48.2

2091

15296

J01EA01

ATC

trimethoprim; systemic

1.6

48.0

1615

11131

5621B

ICD-9 Finland

Diverticula of intestine, Colon[DIVERTICULITIS COLI SINE HAEMORRHAGIA]

+∞

47.9

K59.3

ICD-10 Finland

Megacolon, not elsewhere classified

+∞

47.9

C05AA08

ATC

fluocortolone; rectal, topical

1.9

47.9

824

4668

JFC20

NOMESCO Finland

Other enterocolostomy

104.7

47.8

A03CA02

ATC

clidinium and psycholeptics; oral

2.4

47.8

424

1810

N05BA06

ATC

lorazepam; systemic, sublingual

2.5

47.8

413

1742

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

3.7

47.4

220

615

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

7.5

47.4

114

153

UJK02

NOMESCO Finland

ERCP

3.4

46.8

242

738

D11

ICPC

Diarrhoea

2.1

46.7

553

2709

N05AH02

ATC

clozapine; systemic

5.2

46.6

150

295

E0000UV

ATC

1.5

46.4

2338

17625

107

Kela drug reimbursment

Pernicious anaemia

3.4

46.2

231

686

JFA38

NOMESCO Finland

Endoscopic dilatation of small intestine

100.6

45.8

JFH33

NOMESCO Finland

Total colectomy, mucosal proctectomy, ileoanal anastomosis and ileostomy

100.6

45.8

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.2

45.7

255

822

JN4CD

NOMESCO Finland

Very extensive body CT

2.6

45.6

347

1362

JAL20

NOMESCO Finland

Excision or destruction of lesion of peritoneum

12.7

45.5

LCD00

NOMESCO Finland

Hysterectomy

2.8

45.4

317

1184

J01MA14

ATC

moxifloxacin; systemic

2.0

45.3

620

3222

K62.4

ICD-10 Finland

Stenosis of anus and rectum

231.2

45.0

56500

ICD-8 Finland

Anal fissure and fistula, Anal fissure

+∞

44.8

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

5.8

44.8

130

226

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

13.3

44.7

L28

ICPC

Limited function/disability (L)

1.7

44.7

1090

6878

H02AB07

ATC

prednisone; oral

1.7

44.7

950

5757

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.4

44.5

224

669

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

4.8

44.5

154

328

JFB47

NOMESCO Finland

Laparoscopic resection of sigmoid colon

8.5

44.4

118

AA1AD

NOMESCO Finland

CT of head and brain

1.5

44.4

1627

11411

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.9

44.3

708

3900

5562A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) proctitis

19.9

44.3

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

44.1

2738

21464

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

4.5

44.1

162

367

R03BB04

ATC

tiotropium bromide; inhalant

1.8

43.4

754

4276

JWW96

NOMESCO Finland

Other reoperation in gastroenterological surgery

28.3

43.4

R51.80

ICD-10 Finland

Headache

1.9

43.1

724

4056

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.3

42.8

433

1973

JFK01

NOMESCO Finland

Laparoscopic division of adhesive band in intestinal obstruction

150.8

42.8

4556A

ICD-9 Finland

Haemorrhoids, Unspecified haemorrhoids without mention of complication

+∞

42.7

K50

ICD-10 Finland

Crohn disease [regional enteritis]

23.6

42.6

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.8

42.4

285

1038

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.3

42.3

434

1992

C17.2

ICD-10 Finland

Malignant neoplasm: Ileum

31.3

42.2

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.3

42.1

223

693

D37.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Rectum

6.8

42.1

108

160

B01AB04

ATC

dalteparin; parenteral

2.4

42.0

382

1652

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

41.8

1071

6845

56310

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Ulcerative colitis

10.3

41.7

5621A

ICD-9 Finland

Diverticula of intestine, Colon[DIVERTICULOSIS COLI]

+∞

41.7

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.1

41.6

480

2324

LAF16

NOMESCO Finland

Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer

9.0

41.4

100

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.1

41.3

476

2301

K61.1

ICD-10 Finland

Rectal abscess

409.6

41.1

JF2BD

NOMESCO Finland

Extensive colon CT

9.4

41.1

A06AH03

ATC

naloxegol; oral

5.8

40.9

119

208

L01BB02

ATC

mercaptopurine; oral

8.3

40.8

112

R15

ICD-10 Finland

Faecal incontinence

4.0

40.8

171

439

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

40.7

1582

11214

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

40.6

1638

11707

A06AC51

ATC

ispaghula, combinations; systemic

2.8

40.5

278

1026

M54.5

ICD-10 Finland

Low back pain

1.5

40.5

1786

13015

JFC10

NOMESCO Finland

Ileotransversostomy

34.9

40.3

J02AC01

ATC

fluconazole; systemic

1.5

40.2

2025

15162

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

2.8

40.2

270

985

JHD00

NOMESCO Finland

Anal dilatation

21.2

39.9

K45.8

ICD-10 Finland

Other specified abdominal hernia without obstruction or gangrene

9.0

39.7

6101

FHL

Exploratory laparotomy, includes possible biopases

10.8

39.6

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

8.4

39.3

106

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

4.3

39.2

152

363

JWF00

NOMESCO Finland

Reoperation for insufficiency of anastomosis or suture in gastroenterological surgery

21.3

38.6

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.7

38.5

268

1001

JFB40

NOMESCO Finland

Resection of transverse colon

26.7

38.4

M79.6

ICD-10 Finland

Pain in limb

1.4

38.4

2021

15237

T81.9

ICD-10 Finland

Unspecified complication of procedure

4.1

38.3

153

376

Z43.2

ICD-10 Finland

Attention to ileostomy

23.1

38.3

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

3.7

38.2

173

475

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

4.7

38.2

133

286

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

2.7

37.9

265

991

JGB10

NOMESCO Finland

Partial proctectomy and end colostomy

31.4

37.8

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

37.6

1036

6734

N05AH03

ATC

olanzapine; systemic

2.4

37.6

349

1524

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

3.7

37.3

170

470

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

37.2

2638

20999

G04CA02

ATC

tamsulosin; oral

1.5

37.2

1698

12423

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.5

37.1

1499

10685

JAH33

NOMESCO Finland

Opening of laparostomy

36.3

36.8

6451

FHL

Dilatation

82.5

36.8

JHD20

NOMESCO Finland

Incision of fistula-in-ano

100.5

36.7

WX600

NOMESCO Finland

Single shot through catheter

4.7

36.5

128

277

K51.2

ICD-10 Finland

Ulcerative (chronic) proctitis

5.6

36.4

109

198

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

3.4

36.4

181

537

UJF34

NOMESCO Finland

Left colonoscopy

8.6

36.3

WX610

NOMESCO Finland

Patient controlled analgesia

9.8

36.3

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.1

36.2

416

2008

1470

FHL

Rectoscopy

15.1

36.0

K55.9

ICD-10 Finland

Vascular disorder of intestine, unspecified

358.9

36.0

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.4

35.9

330

1433

D10

ICPC

Vomiting

2.7

35.8

260

995

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

2.2

35.8

372

1715

A04

ICPC

Weakness/tiredness general

1.7

35.8

766

4630

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

35.8

1063

7040

JFA00

NOMESCO Finland

Enterotomy

98.0

35.7

N05AF03

ATC

chlorprothixene; systemic

3.3

35.7

183

556

C56

ICD-10 Finland

Malignant neoplasm of ovary

9.0

35.6

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

3.5

35.5

175

515

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

4.0

35.4

147

375

J01AA02

ATC

doxycycline; systemic

1.4

35.4

5011

44625

D50.8

ICD-10 Finland

Other iron deficiency anaemias

5.0

35.4

116

234

K91.3

ICD-10 Finland

Postoperative intestinal obstruction

52.7

35.4

N03AE01

ATC

clonazepam; systemic

2.3

35.3

356

1619

L04AB04

ATC

adalimumab; parenteral

4.2

35.2

136

325

WVA20

NOMESCO Finland

Medicine administration

3.5

35.1

171

499

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

9.9

35.1

R60.0

ICD-10 Finland

Localized oedema

1.8

35.1

706

4190

JGC01

NOMESCO Finland

Laparoscopic rectopexy

34.8

34.9

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

11.3

34.8

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

4.2

34.7

136

329

JFB96

NOMESCO Finland

Other partial excision of intestine

95.5

34.7

N06AX16

ATC

venlafaxine; oral

1.8

34.6

657

3825

6419

FHL

Other measure in this category

36.9

34.6

WX872

NOMESCO Finland

Intensive care

2.2

34.4

362

1677

JX1LA

NOMESCO Finland

Kinetic X-ray of alimentary tract with pictures

25.4

34.4

C18.61

ICD-10 Finland

Malignant tumor of the colon descending invasive carcinoma

13.4

34.3

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

3.0

34.2

208

711

C56.00

ICD-10 Finland

Malignant tumor of the ovary without histology

7.8

34.2

104

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

34.1

902

5787

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

5.9

34.1

166

F20.9

ICD-10 Finland

Schizophrenia, unspecified

3.6

34.0

159

449

K63.9

ICD-10 Finland

Disease of intestine, unspecified

26.2

34.0

XX3DW

NOMESCO Finland

Time consuming IT work

1.8

34.0

676

3995

SPAT1167

SPAT

Insertion of urinary catheter

2.6

33.9

263

1047

56300

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Regional enteritis

21.0

33.8

R52.2

ICD-10 Finland

Other chronic pain

2.9

33.7

208

720

JFG36

NOMESCO Finland

Closure of terminal colostomy with anastomosis to rectum

120.5

33.7

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

4.5

33.6

121

270

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.5

33.6

163

475

A07EC01

ATC

sulfasalazine; oral, rectal

1.9

33.6

492

2616

K83.0

ICD-10 Finland

Cholangitis

3.9

33.2

139

358

JFG30

NOMESCO Finland

Closure of colostomy with resection of exteriorised loop

63.6

33.0

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

5.3

33.0

102

193

JAL00

NOMESCO Finland

Biopsy of peritoneum

9.0

32.9

N03AG01

ATC

valproic acid; systemic, rectal

2.2

32.8

363

1723

JFF11

NOMESCO Finland

Laparoscopic loop enterostomy

16.2

32.8

K31.5

ICD-10 Finland

Obstruction of duodenum

30.9

32.5

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.9

32.5

493

2656

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.1

32.4

384

1876

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

6.3

32.3

139

5552A

ICD-9 Finland

Regional enteritis, Small intestine with large intestine

54.5

32.2

L01BC59

ATC

trifluridine, combinations; systemic

18.0

32.2

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

32.1

2019

15627

8240/3-C17.9

ICD-O-3

Neuroendocrine tumor, NOS, of small intestine, NOS

40.2

32.1

JGB50

NOMESCO Finland

Mucosal proctectomy and ileoanal anastomosis

61.9

32.0

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

3.2

31.9

173

548

D29

ICPC

Digestive symptom/complaint other

4.0

31.9

133

341

D02

ICPC

Abdominal pain epigastric

2.3

31.9

306

1357

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.8

31.9

558

3162

5568X

ICD-9 Finland

Idiopathic proctocolitis, Other ulcerative colitis

16.6

31.8

JFG50

NOMESCO Finland

Laparotomy with revision of enterostomy or colostomy

72.4

31.8

R13

ICD-10 Finland

Dysphagia

2.0

31.7

401

2013

SPAT1229

SPAT

Assessment of need for aid

1.8

31.7

562

3196

R03AC02

ATC

salbutamol; inhalant

1.3

31.6

2979

24658

K30

ICD-10 Finland

Functional dyspepsia

1.9

31.5

526

2933

WX725

NOMESCO Finland

Noninvasive ventilation

2.3

31.5

302

1342

C18.09

ICD-10 Finland

Malignant tumor of caecum other or unspecified histology

10.4

31.5

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

31.5

1034

6999

C18.11

ICD-10 Finland

Malignant tumor of the appendix invasive carcinoma

16.0

31.5

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

31.5

1856

14194

JH1CG

NOMESCO Finland

Extensive MRI of perianal area

27.0

31.4

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.8

31.4

545

3078

4550A

ICD-9 Finland

Haemorrhoids, Internal haemorrhoids without mention of complication

+∞

31.3

5650B

ICD-9 Finland

Anal fissure and fistula, Anal fissure[FISSURA ANI TYPICA]

+∞

31.3

WX730

NOMESCO Finland

Conventional respirator

3.6

31.1

146

415

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

6.8

31.0

117

A46

ICD-10 Finland

Erysipelas

1.6

30.9

926

6124

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

12.2

30.8

K62.8

ICD-10 Finland

Other specified diseases of anus and rectum

18.9

30.8

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.1

30.7

173

564

K63.8

ICD-10 Finland

Other specified diseases of intestine

110.4

30.7

XX1XW

NOMESCO Finland

Extensive written report from radiologist

3.2

30.6

163

511

JFH20

NOMESCO Finland

Proctocolectomy and ileostomy

46.4

30.5

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.6

30.4

876

5737

369

Kela drug reimbursment

Regorafenib

19.3

30.4

D28

ICPC

Limited function/disability (D)

13.3

30.3

C18.90

ICD-10 Finland

Malignant tumor in unspecified location in the colon without histology

8.4

30.3

RD210

NOMESCO Finland

3.9

30.2

127

329

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

4.3

30.2

115

272

N30.9

ICD-10 Finland

Cystitis, unspecified

2.1

30.1

348

1682

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

3.1

29.9

168

547

Z71.8

ICD-10 Finland

Other specified counselling

1.5

29.9

1226

8718

N06AB10

ATC

escitalopram; oral

1.6

29.9

929

6199

K51

ICD-10 Finland

Ulcerative colitis

6.9

29.8

109

XX4AT

NOMESCO Finland

Other canalization with ultrasound guidance

11.8

29.8

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.8

29.7

568

3308

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

29.7

823

5338

K29.7

ICD-10 Finland

Gastritis, unspecified

2.6

29.5

217

837

WX290

NOMESCO Finland

Other blockade of nerve

1.4

29.5

2118

16720

JFF26

NOMESCO Finland

Sigmoidostomy

18.8

29.5

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3042936) Bacteria identified in Isolate by Culture

2030

8547

2.82

321.83

2.7

1.9

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1670

6377

3.03

316.41

4.0

2.6

9.5

9.8

umol/l

0.18

1485

5549

(3048689) Calprotectin [Mass/mass] in Stool

1370

4682

3.31

313.53

3.9

2.0

252.2

146.2

ug/g

10.51

1175

3628

(3023368) Bacteria identified in Blood by Culture

3812

17924

3.09

307.65

6.4

4.1

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1625

3911

4.92

307.65

2.1

1.6

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1539

5007

3.55

307.65

3.7

2.3

37.1

50.7

u/l

0.75

1392

4242

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

4304

17843

3.94

307.65

4.0

2.4

56.3

60.0

u/l

4.16

4127

16311

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

2102

6397

4.06

307.65

6.4

3.9

17.5

28.0

ug/l

1.41

1801

5280

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2314

10140

2.78

307.65

5.3

3.1

0.8

mmol/l

9.27

2200

9366

(3014576) Chloride [Moles/volume] in Serum or Plasma

2048

7915

3.11

307.65

10.5

6.5

103.8

104.5

mmol/l

7.33

2008

7721

(3032080) INR in Blood by Coagulation assay

4498

26970

2.46

307.65

11.8

9.8

1.2

1.3

inr

14.38

1415

7597

(3024561) Albumin [Mass/volume] in Serum or Plasma

4805

27297

2.81

307.65

10.0

4.4

32.7

35.0

g/l

111.72

4573

24995

(3013650) Neutrophils [#/volume] in Blood by Automated count

5286

34579

2.46

307.65

16.4

8.5

4.5

4.2

e9/l

10.94

4786

29826

(3044640) Blood type and Crossmatch panel - Blood

3679

18924

2.70

307.65

3.9

2.3

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1600

5484

3.37

307.65

3.0

2.1

0.2

g/l

1.40

1495

5046

(3014111) Lactate [Moles/volume] in Serum or Plasma

1570

5415

3.34

307.65

7.1

6.5

1.4

mmol/l

0.23

1523

5178

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

891

2155

4.51

307.65

4.8

3.3

1380.2

2604.8

u/ml

0.40

774

1840

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

5704

31586

3.59

307.65

11.1

5.9

11.3

12.2

umol/l

4.86

5550

29815

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

4685

28136

2.53

307.65

6.3

3.9

—

(3022145) Colonoscopy Study observation

1522

4773

3.68

307.65

1.7

1.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2812

14264

2.47

301.45

3.7

2.2

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

5452

37262

2.35

285.94

7.8

4.4

6.8

6.9

mmol/l

0.62

5271

34836

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2923

15441

2.38

282.59

3.0

2.1

3.2

3.0

mg/l

4.69

2562

13016

(3002032) Base excess in Venous blood by calculation

1513

5895

2.92

273.13

5.2

3.7

2.3

1.9

mmol/l

2.50

1257

4766

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

710

1692

4.49

272.42

1.5

1.2

—

(3012544) pH of Venous blood

1555

6162

2.87

271.96

5.1

3.7

7.4

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1519

5948

2.90

271.58

5.2

3.7

5.8

kpa

0.24

1481

5759

(3000991) Gas panel - Venous blood

1372

5179

2.98

261.55

9.4

7.7

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

6423

48058

2.50

260.13

14.8

7.0

88.0

80.3

u/l

15.46

6233

44787

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1829

8179

2.59

250.22

6.8

5.4

1.0

mmol/l

0.48

1723

7522

(3016502) Oxygen saturation in Arterial blood

1579

6685

2.68

240.59

9.1

7.0

95.8

95.5

1.21

1521

6411

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3186

18476

2.18

236.59

4.9

3.1

35.2

35.8

u/l

0.13

3022

17376

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

4774

32296

2.13

236.50

10.3

6.3

1.2

mmol/l

34.12

4047

26849

(3026008) Bacteria identified in Urine by Culture

3295

19410

2.16

234.54

4.4

3.1

—

(3003396) Base excess in Arterial blood by calculation

1688

7492

2.57

232.87

8.9

6.6

1.3

1.1

mmol/l

0.76

1391

5787

(3020779) Urea [Moles/volume] in Serum or Plasma

1406

5746

2.74

228.78

8.2

6.6

10.2

10.6

mmol/l

1.05

1341

5430

(3027801) Oxygen [Partial pressure] in Arterial blood

1680

7510

2.55

227.84

8.8

6.6

12.7

12.1

kpa

4.31

1603

7108

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1680

7512

2.55

227.70

8.8

6.6

5.1

kpa

0.40

1606

7121

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1457

6081

2.69

227.35

9.5

7.4

117.3

121.4

g/l

11.10

1414

5844

(3022948) Iron [Moles/volume] in Serum or Plasma

1970

9568

2.39

222.26

3.1

2.4

11.1

12.8

umol/l

16.65

1848

8770

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

4380

29263

2.05

217.21

9.4

5.6

1.2

mmol/l

36.83

4056

26223

(3006315) Basophils [#/volume] in Blood

4436

29816

2.05

215.85

8.5

5.4

0.0

e9/l

1.51

3917

25335

(3013115) Eosinophils [#/volume] in Blood

4537

30753

2.05

215.54

8.9

5.6

0.2

e9/l

8.46

4034

26567

(3000850) Epithelial cells [#/volume] in Urine

2469

13346

2.21

214.85

3.4

2.6

6.0

5.1

e6/l

1.79

2222

11611

(3001604) Monocytes [#/volume] in Blood

4410

29655

2.04

213.40

8.4

5.4

0.6

e9/l

0.71

3894

25183

(3019198) Lymphocytes [#/volume] in Blood

4489

30516

2.03

209.09

8.5

5.5

1.8

1.9

e9/l

5.06

4005

26433

(3026782) Osmolality of Urine

2342

12547

2.21

207.15

3.8

2.7

532.3

553.3

mosm/kgh2o

4.79

2073

10638

(3031040) Bacteria [#/volume] in Urine by Automated count

5563

41010

2.08

204.77

6.9

4.3

1960.8

1662.6

e6/l

0.13

114

682

(3002582) Erythrocytes [#/volume] in Urine

3195

19336

2.06

204.75

4.5

3.2

57.8

94.7

e6/l

2.38

2650

14748

(3024354) Oxygen [Partial pressure] in Venous blood

1213

4880

2.74

201.79

4.3

3.1

4.7

4.5

kpa

1.90

1179

4699

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1817

8846

2.35

201.56

3.1

2.4

2.3

g/l

0.11

1695

8130

(3019069) Monocytes/100 leukocytes in Blood

4184

28003

2.00

200.70

8.9

5.9

8.8

0.06

3972

25969

(42870588) Differential panel, method unspecified - Blood

3299

20342

2.03

199.44

7.8

5.5

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1732

8300

2.37

198.95

3.1

2.5

19.8

22.6

11.51

1501

6989

(3022096) Basophils/100 leukocytes in Blood

4067

27021

1.99

198.51

8.5

5.7

0.6

0.7

9.68

3855

24963

(3006504) Eosinophils/100 leukocytes in Blood

4153

27852

1.98

196.65

8.6

5.7

2.5

2.9

18.44

3936

25710

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2049

10594

2.24

196.35

2.2

1.8

—

(3002030) Lymphocytes/100 leukocytes in Blood

4240

28675

1.98

195.54

8.7

5.8

24.3

26.8

37.53

4004

26430

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

841

2871

3.15

188.09

5.2

4.0

24.2

24.1

mmol/l

0.18

783

2536

(3018010) Neutrophils/100 leukocytes in Blood

4159

28217

1.95

187.05

8.4

5.6

60.6

58.1

28.95

3935

26133

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

982

3678

2.89

186.28

7.5

6.9

25.0

24.8

mmol/l

1.06

971

3641

(3033658) Prothrombin time (PT) actual/Normal

2649

15432

2.05

184.26

7.3

3.7

86.0

86.9

1.09

2596

15043

(3030467) Casts [#/volume] in Urine by Automated count

2921

17657

2.01

182.97

4.4

3.1

0.7

0.5

e6/l

2.80

2381

13245

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3618

23657

1.94

179.21

3.9

2.6

150.7

152.8

ug/l

0.14

3329

21499

(3018095) Leukocytes [#/volume] in Urine

3441

22191

1.94

177.02

5.2

3.6

158.3

112.2

e6/l

1.52

2758

15752

(3025941) Bacteria identified in Stool by Culture

776

2631

3.15

175.17

1.5

1.2

—

(3014007) Fractional oxyhemoglobin in Arterial blood

1001

3959

2.74

170.56

10.1

8.5

94.1

93.9

0.76

994

3940

(36304419) Bacteria [Presence] in Urine

2800

17018

1.97

169.92

4.3

3.0

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

496

1281

4.05

169.57

1.5

1.4

226.7

265.8

ug/g

3.65

308

782

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3729

25014

1.89

167.33

5.0

3.6

32.9

77.6

ng/l

1.94

2959

18346

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

485

1269

4.00

162.76

4.8

3.1

357.8

635.1

u/ml

0.63

452

1170

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

920

3647

2.71

155.38

1.7

1.4

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

970

3973

2.63

153.39

10.3

8.4

0.7

4.56

961

3938

(40768797) Stomach Pathology biopsy report

1433

7083

2.24

148.79

1.4

1.2

—

(3019060) Gas panel - Arterial blood

1031

4422

2.52

147.89

6.7

4.5

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

961

3995

2.59

147.13

10.3

8.3

1.3

1.4

1.01

952

3964

(40758558) Short blood count panel - Blood

2477

15045

1.92

146.17

12.4

6.6

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

734

2679

2.91

144.61

2.4

1.9

2.9

2.4

ug/l

0.46

662

2342

(3015377) Calcium [Moles/volume] in Serum or Plasma

3201

21356

1.81

138.44

5.2

3.3

2.3

2.4

mmol/l

20.48

2875

18386

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1421

7331

2.13

130.96

2.1

1.7

—

(3018418) pH of Serum or Plasma

2915

19185

1.80

129.86

5.6

3.9

7.4

1.78

647

3761

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1418

7351

2.12

128.85

2.1

1.7

—

(3037467) Urinalysis macro (dipstick) panel - Urine

5405

42500

1.78

128.43

6.4

4.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

829

3425

2.58

127.77

11.0

9.0

—

(3027945) Reticulocytes/100 erythrocytes in Blood

1417

7370

2.11

127.54

2.7

2.4

1.8

1.54

1243

6453

(3007853) Bacteria identified in Skin by Aerobe culture

1367

7052

2.12

125.54

2.3

1.7

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

950

4228

2.41

124.63

10.1

6.7

24.9

24.7

mmol/l

0.81

902

3922

(3013005) Retinol [Moles/volume] in Serum or Plasma

140

146

9.73

120.11

3.7

1.5

2.1

umol/l

0.02

131

138

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2075

12548

1.87

120.06

2.1

1.7

1.6

1.4

mg/l

2.57

1742

9637

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

619

2282

2.85

119.08

3.2

2.8

0.3

0.4

u/ml

1.04

351

1303

(3004119) Hemoglobin [Mass/volume] in Venous blood

882

3907

2.41

116.56

4.3

3.3

125.0

128.4

g/l

3.83

853

3822

(4035726)

1126

5619

2.16

111.70

1.5

1.4

—

(3018405) Lactate [Moles/volume] in Arterial blood

611

2324

2.76

110.58

6.0

4.0

1.4

mmol/l

0.28

589

2286

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

313

787

4.09

110.53

7.4

6.0

12.8

11.8

mg/l

2.66

287

716

(3019309) Folate [Moles/volume] in Red Blood Cells

2083

12951

1.81

108.45

2.0

1.8

1216.9

1173.9

nmol/l

1.19

1604

9614

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1716

10072

1.89

107.37

2.5

2.0

30.5

30.0

2.32

1671

9765

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

373

1089

3.54

106.19

1.5

1.4

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

708

2997

2.49

102.88

3.8

2.7

1.3

1.2

1.51

703

2976

(40760892) CBC W Ordered Manual Differential panel - Blood

2009

12563

1.79

101.57

6.5

4.3

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1358

7510

1.97

101.02

3.7

4.1

229.9

253.7

u/l

8.61

1274

7063

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3397

24566

1.65

100.10

3.1

2.1

75.3

78.5

nmol/l

7.15

3087

21648

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

4753

37362

1.64

100.08

4.7

2.9

64.8

52.3

u/l

8.98

4460

34098

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

690

2942

2.47

98.58

3.7

2.6

0.7

0.53

675

2797

(3009261) Glucose [Presence] in Urine by Test strip

3999

30333

1.61

95.64

5.3

3.6

0.0

estimate

1.98

935

5461

(3023520) Reticulocytes [#/volume] in Blood

1073

5583

2.06

94.30

2.7

2.5

70.5

68.4

e9/l

0.96

792

4223

(3009343) pH of Capillary blood

849

4044

2.22

93.75

5.0

3.6

7.4

0.35

122

531

(3027273) Bicarbonate [Moles/volume] in Venous blood

726

3241

2.36

93.47

4.8

3.3

25.4

25.2

mmol/l

0.62

704

3145

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

856

4100

2.21

93.22

5.0

3.6

5.1

5.2

kpa

0.59

797

3778

(3021601) Nitrite [Presence] in Urine by Test strip

3951

30004

1.60

93.11

6.9

4.8

0.0

estimate

0.80

940

5639

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1742

10683

1.80

92.91

3.6

2.7

1.5

1.4

e6/l

0.11

1039

6090

(3036481) Cortisol [Moles/volume] in Serum or Plasma

972

4909

2.11

92.42

2.5

2.3

390.9

382.3

nmol/l

0.38

884

4487

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

738

3342

2.33

91.88

10.6

8.6

24.1

24.3

mmol/l

0.73

701

3066

(3035350) Ketones [Presence] in Urine by Test strip

3938

29948

1.60

91.76

5.3

3.6

0.0

estimate

0.80

933

5574

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1645

9955

1.81

91.56

3.9

2.9

3.0

2.3

e6/l

1.20

950

5412

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

821

3908

2.22

90.68

4.9

3.5

2.0

mmol/l

0.19

620

2862

(3021960) Folate [Moles/volume] in Serum or Plasma

2275

15154

1.69

89.95

1.8

1.5

20.9

20.0

nmol/l

1.73

1988

12846

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

101

100

10.21

89.93

3.2

3.3

6.3

7.1

mg/l

0.52

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

439

1562

2.91

89.70

2.9

2.6

3.7

3.6

g/l

0.50

426

1481

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

606

2540

2.49

89.59

7.6

3.6

107.0

89.9

u/ml

0.42

583

2446

(3021589) Normoblasts [#/volume] in Blood

3627

27198

1.59

88.63

17.9

9.4

0.0

e9/l

0.49

3064

22127

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1946

12500

1.73

87.60

4.5

3.7

389.8

558.0

ng/l

0.51

1563

10353

(40768804) Tissue Pathology biopsy report

3262

23928

1.60

87.02

2.5

2.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

385

1319

3.01

84.13

1.3

1.1

—

(3020891) Body temperature

611

2645

2.41

84.05

7.8

4.6

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

252

661

3.90

83.85

5.3

3.2

13.9

14.5

nmol/l

0.02

245

648

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1866

11983

1.72

83.49

5.4

3.0

2.5

mmol/l

4.50

1675

10382

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

382

1312

3.00

83.09

1.3

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

383

1324

2.98

82.35

1.3

1.1

—

(3015736) pH of Urine

3161

23249

1.58

81.96

4.8

3.4

—

5.7

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1217

6933

1.88

81.31

5.6

3.4

—

(3017181) Myelocytes/100 leukocytes in Blood

983

5228

2.00

80.51

4.3

3.9

1.0

0.9

0.36

385

1499

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

662

3025

2.29

80.35

5.4

3.9

49.7

47.2

1.76

653

2980

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

476

1881

2.62

79.37

2.1

1.6

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3519

26662

1.56

79.25

2.5

2.0

87.5

94.5

pmol/l

17.27

2175

13726

(3010421) pH of Blood

448

1725

2.69

78.67

5.1

3.8

7.4

0.07

385

1461

(3023183) Ammonium ion [Moles/volume] in Plasma

358

1226

3.01

78.24

2.8

2.3

32.9

umol/l

0.00

300

1028

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

231

603

3.91

77.38

1.6

1.4

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

612

2759

2.31

76.58

6.9

4.8

0.9

0.89

576

2587

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

771

3839

2.11

75.38

2.0

1.7

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

233

624

3.81

75.26

1.6

1.4

—

(3047181) Lactate [Moles/volume] in Blood

491

2023

2.52

75.02

7.9

5.6

1.4

1.3

mmol/l

0.23

415

1788

(3005988) Vibrio sp identified in Specimen by Organism specific culture

228

605

3.84

74.62

1.6

1.4

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

614

2802

2.29

74.60

6.8

4.7

1.6

0.36

578

2624

(3022217) INR in Platelet poor plasma by Coagulation assay

1488

9232

1.74

74.29

25.4

27.5

1.4

inr

0.33

258

1173

(3024522) Salmonella sp identified in Specimen by Organism specific culture

229

612

3.82

74.19

1.6

1.4

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

9.26

73.86

2.4

2.6

141.4

142.3

au/ml

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

226

605

3.81

73.04

1.6

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

225

603

3.81

72.60

1.6

1.4

—

(3012501) Base excess in Blood by calculation

394

1497

2.71

70.94

5.3

3.8

3.1

2.7

mmol/l

1.58

284

996

(3013290) Carbon dioxide [Partial pressure] in Blood

394

1498

2.71

70.85

5.3

3.8

5.0

kpa

0.13

385

1461

(3043409) Potassium [Moles/volume] in Arterial blood

478

1999

2.48

70.68

6.5

4.2

3.8

3.9

mmol/l

3.17

442

1864

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

130

228

5.77

70.56

16.3

15.6

7181.2

1410.8

nmol/l

0.51

123

222

(1616796) Gas panel - Central venous blood

391

1485

2.71

70.45

4.1

3.5

—

(3027315) Oxygen [Partial pressure] in Blood

394

1507

2.69

70.01

5.3

3.8

8.8

8.5

kpa

2.09

385

1469

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2767

20284

1.55

69.82

3.3

3.0

1853.1

1696.0

ng/l

0.70

2411

17489

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

617

2913

2.21

68.90

1.7

1.6

1.7

1.5

g/l

3.48

541

2446

(3013707) Erythrocyte sedimentation rate by Westergren method

5342

45087

1.52

67.87

5.0

3.8

16.2

13.4

mm/h

24.92

4938

41190

(3003181) Sodium [Moles/volume] in Urine

318

1104

2.95

67.77

2.2

1.3

61.0

63.4

mmol/l

0.36

227

896

(3015235) Bicarbonate [Moles/volume] in Capillary blood

420

1691

2.56

67.26

3.8

3.1

24.7

24.9

mmol/l

0.25

371

1487

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

407

1614

2.60

67.24

2.7

2.3

84.8

90.3

4.25

395

1507

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

378

1451

2.68

66.67

2.9

2.6

217.0

197.4

3.29

364

1385

(4281824)

216

598

3.68

66.49

1.2

1.1

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

124

222

5.65

65.87

11.9

11.8

866.6

819.6

nmol/l

0.43

117

211

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2681

19712

1.53

65.80

2.5

2.1

233.5

240.2

u/l

0.08

2521

18346

(3028626) Oxygen [Partial pressure] in Capillary blood

384

1498

2.64

65.57

4.4

3.2

8.0

kpa

0.08

350

1393

(3021440) Promyelocytes/100 leukocytes in Blood

901

4984

1.91

64.98

4.5

3.9

0.1

0.2

1.08

337

1398

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1027

5929

1.83

64.74

2.7

2.3

4.9

7.6

ug/l

8.07

881

5101

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

104

8.24

64.42

3.0

1.7

9.0

9.3

mg/l

0.12

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

6885

61847

1.67

63.86

35.7

13.9

32.5

25.7

mg/l

46.70

6400

49030

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2042

14218

1.58

63.57

2.0

1.7

434.3

27025347.2

pmol/l

8.92

1686

11519

(3002179) Metamyelocytes/100 leukocytes in Blood

859

4749

1.90

61.91

4.1

3.8

0.7

0.10

256

1087

(3029937) Albumin [Presence] in Urine by Test strip

2305

16738

1.52

58.46

6.0

4.0

0.0

estimate

0.52

889

5346

(3017143) Hepatitis C virus Ab [Presence] in Serum

910

5219

1.83

58.25

1.6

1.5

—

(3000494) Fungus identified in Specimen by Culture

1100

6681

1.74

57.96

1.8

1.4

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1410

9158

1.65

57.81

1.5

2.7

2.6

g/l

0.52

906

5448

(3002256) Pathology report gross observation

1264

7994

1.68

57.40

1.4

1.3

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

9.14

56.80

2.2

1.5

121.5

81.0

au/ml

—

(3037121) Protein [Mass/volume] in Urine

460

2083

2.28

56.63

4.6

3.0

0.2

0.3

g/l

2.10

301

862

(3025159) Blasts/100 leukocytes in Blood

830

4674

1.86

56.24

4.5

4.0

0.1

0.4

1.77

283

1174

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3016

23277

1.46

56.00

5.8

3.8

—

(3022313) Gas panel - Capillary blood

582

2909

2.08

55.82

5.2

3.7

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

375

1566

2.46

55.48

1.7

1.5

9.3

5.8

iu/ml

0.14

364

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

291

1080

2.75

54.76

6.7

5.4

1256.7

1858.5

iu/ml

0.16

158

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

473

2212

2.21

53.82

2.6

2.2

602.4

690.2

ug/l

0.24

450

2089

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1536

10383

1.59

52.96

1.3

1.2

1.5

2.2

u/ml

1.27

406

2737

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

19.61

52.80

1.6

2.0

—

(3036489) Thrombin time

447

2063

2.23

52.52

2.5

2.0

21.5

0.05

415

1815

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

982

5954

1.74

51.68

1.6

1.5

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

107

214

5.05

50.34

3.4

1.3

17.4

25.7

umol/l

2.20

102

203

(3021901) Oxygen saturation in Capillary blood

311

1254

2.54

49.56

3.1

2.9

—

(3003327) Ova and parasites identified in Stool by Light microscopy

317

1300

2.49

48.74

1.5

1.7

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

629

3387

1.93

48.67

3.5

2.8

0.6

0.3

e6/l

2.20

615

3312

(3052851) Hemolysis interference index of Serum or Plasma

398

1810

2.26

48.42

5.1

3.3

—

(40767503) Oxygen content in Capillary blood by calculation

336

1423

2.42

48.17

3.0

2.5

15.5

16.1

1.42

165

748

(3039000) Anion gap in Blood

346

1488

2.38

47.93

9.4

6.3

11.1

11.2

mmol/l

0.27

317

1330

(3018572) Chloride [Moles/volume] in Blood

346

1489

2.38

47.86

9.4

6.3

105.2

105.1

mmol/l

0.09

317

1331

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

144

379

3.85

47.75

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

142

371

3.87

47.57

1.4

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

271

1044

2.65

47.41

1.6

1.4

244.9

192.3

pmol/l

0.81

261

1016

(3020630) Protein [Mass/volume] in Serum or Plasma

909

5519

1.73

47.37

2.7

2.5

65.4

66.2

g/l

2.40

819

4940

(40762365) Oxygen content in Arterial blood by calculation

7.24

46.89

3.5

2.6

14.4

14.7

ml/dl

0.36

(3041096) Erythrocytes [Presence] in Urine by Automated

2137

15869

1.47

46.49

5.1

3.3

—

(3024928) Oxygen saturation in Venous blood

300

1238

2.48

45.51

3.1

—

(3005719) IgG [Mass/volume] in Serum or Plasma

714

4093

1.81

45.28

2.6

2.7

10.3

10.6

g/l

0.85

648

3709

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

509

2618

2.00

44.93

2.3

1.9

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

114

264

4.36

44.93

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

114

264

4.36

44.93

1.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

478

2406

2.05

44.80

2.2

1.8

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

427

2070

2.12

44.24

1.4

1.3

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

780

4636

1.75

43.68

4.7

3.6

103.2

93.2

ng/l

1.60

660

3906

(46235355) HIV 1 and 2 tests - Meaningful Use set

1079

7007

1.62

43.19

1.8

1.6

—

(40761536) Microorganisms panel - Urine sediment

867

5333

1.70

42.86

5.9

3.8

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

330

1463

2.31

42.62

1.8

1.6

—

(3013512) EKG study

2463

19081

1.41

41.64

4.8

3.9

—

(3028026) IgM [Mass/volume] in Serum or Plasma

573

3172

1.87

40.55

1.9

1.8

1.3

1.4

g/l

0.12

523

2834

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

221

4.47

39.98

2.7

2.5

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

176

592

3.01

39.72

1.3

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

899

5696

1.65

39.52

5.0

3.7

1.2

mmol/l

6.22

804

4875

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

313

1419

2.25

38.34

1.8

1.6

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

225

4.35

38.19

1.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

228

4.29

37.55

1.3

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

467

2496

1.92

36.77

5.9

3.8

24.8

24.9

mmol/l

0.44

426

2269

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

224

905

2.51

35.58

1.4

1.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

314

1479

2.17

35.00

2.6

2.2

124.2

127.4

g/l

1.28

253

1102

(3016038) Potassium [Moles/volume] in Urine

129

389

3.35

34.97

2.4

1.2

33.4

35.2

mmol/l

0.33

113

323

(3051651) Icteric interference index of Serum or Plasma

119

341

3.52

34.92

6.1

3.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

261

1143

2.32

34.70

1.6

1.5

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1876

14240

1.41

34.43

5.0

3.6

—

(3004809) Band form neutrophils/100 leukocytes in Blood

246

1059

2.36

34.02

3.3

3.5

1.6

1.4

0.45

191

807

(3017315) Amylase [Enzymatic activity/volume] in Urine

243

3.98

33.71

1.3

1.1

233.9

385.8

u/l

1.22

219

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3796

32237

1.33

33.58

3.0

2.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

244

1068

2.32

32.49

1.7

1.6

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

248

1096

2.30

32.30

1.7

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

293

1406

2.12

31.16

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

292

1406

2.12

30.78

1.5

1.3

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

224

968

2.35

30.74

1.6

1.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

422

2322

1.86

30.33

2.6

2.7

—

(3019977) pH of Arterial blood

119

374

3.21

30.23

4.4

2.4

7.4

0.28

136

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

205

863

2.41

29.84

1.6

1.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

204

867

2.39

29.08

1.8

1.5

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

875

5901

1.54

29.07

3.1

2.9

231.0

229.0

ng/l

0.04

802

5388

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

103

307

3.38

28.51

3.3

3.8

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

112

5.21

28.50

2.5

3.1

1671.7

2571.7

u/l

0.26

106

(3019550) Sodium [Moles/volume] in Serum or Plasma

6957

65205

1.42

28.29

39.2

16.7

138.9

139.7

mmol/l

107.92

6834

63316

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

157

599

2.65

28.12

3.1

2.7

—

(3019150) Specific gravity of Urine by Refractometry

1721

13271

1.37

27.86

5.8

4.0

1.0

kg/l

0.86

267

1919

(3007566) Smooth muscle Ab [Titer] in Serum

276

1355

2.07

27.65

1.2

132.4

175.5

titre

0.27

118

(3004588) Protein electrophoresis panel - Serum or Plasma

701

4555

1.59

27.38

2.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

202

884

2.32

26.97

1.5

1.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

309

1604

1.96

26.51

4.0

3.2

1.8

1.6

mg/l

2.11

283

1441

(3023103) Potassium [Moles/volume] in Serum or Plasma

6957

65372

1.40

26.38

39.2

16.8

4.0

mmol/l

11.45

6827

63361

(3037522) Nuclear Ab [Titer] in Serum

1002

7101

1.47

26.02

1.4

1.3

543.9

504.5

titre

0.26

238

1520

(3003694) ABO and Rh group [Type] in Blood

1996

15892

1.34

25.95

1.4

1.3

—

(40761535) Cells panel - Urine sediment

795

5380

1.53

25.87

4.8

3.4

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

190

825

2.33

25.84

3.4

2.7

1473.0

1775.7

u/ml

0.10

(3024980) IgG subclass 4 [Mass/volume] in Serum

183

792

2.34

25.09

1.4

1.6

0.7

0.8

g/l

0.70

127

587

(3009466) Valproate [Moles/volume] in Serum or Plasma

190

837

2.30

25.00

5.8

4.6

350.7

356.8

umol/l

0.22

171

700

(3008037) Lactate [Moles/volume] in Venous blood

297

1556

1.94

24.81

4.2

3.1

1.6

1.7

mmol/l

1.06

291

1520

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

181

786

2.33

24.63

2.4

2.1

2335.5

3345.6

u/l

0.25

314

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

492

3006

1.68

24.58

2.3

2.4

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

151

605

2.52

24.52

1.4

1.2

59.2

64.5

u/l

0.47

111

401

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

167

704

2.40

24.31

1.8

1.5

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

546

3451

1.62

23.87

1.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

278

1444

1.96

23.83

1.6

1.7

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

211

3.62

23.51

2.3

1.8

1259.8

7096.0

e6/l

0.69

139

(3009445) Proteinase 3 Ab [Units/volume] in Serum

433

2592

1.71

23.35

1.5

1.6

10.3

19.4

u/ml

0.95

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

372

2147

1.77

22.84

3.2

40.2

46.2

mg/l

0.65

289

1731

(3034860) Kappa light chains.free [Mass/volume] in Serum

372

2148

1.77

22.81

3.2

88.9

57.4

mg/l

0.95

291

1730

(3049717) Cytology report of Urine Cyto stain

439

2656

1.69

22.75

2.9

2.8

—

(40768441) Liver Pathology biopsy report

111

404

2.77

21.88

1.4

1.3

—

(3008295) Osmolality of Serum or Plasma

145

606

2.42

21.56

1.3

1.4

276.3

279.2

mosm/kgh2o

0.63

108

474

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

359

2087

1.75

21.50

3.1

7.1

2.4

ratio

0.75

177

(3033705) Calcium.ionized [Moles/volume] in Venous blood

190

892

2.16

21.47

2.9

2.3

—

(3044889) 12 lead EKG panel

4958

44951

1.26

21.45

4.7

3.9

—

(3001186) Copper [Moles/volume] in Serum or Plasma

103

4.68

20.95

1.9

1.1

16.8

16.7

umol/l

0.05

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

101

358

2.84

20.93

2.6

1.7

—

(3051611) Lipemic interference index of Serum or Plasma

151

652

2.34

20.88

5.8

3.0

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

186

3.62

20.77

2.1

1.7

7501.8

17440.5

e6/l

0.41

(3044007) Cell count panel - Peritoneal fluid

177

3.69

20.73

1.8

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

128

517

2.50

20.51

1.7

1.5

—

(3038515) Glucose [Moles/volume] in Venous blood

272

1479

1.87

20.34

4.4

3.2

7.6

7.7

mmol/l

0.54

267

1449

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

331

2.89

20.33

1.5

1.2

113.1

89.0

u/l

1.09

277

(3022493) Free Hemoglobin [Mass/volume] in Plasma

233

3.28

20.23

3.2

4.2

2115.9

72.3

mg/l

0.49

156

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

162

732

2.24

20.15

1.3

0.1

0.3

nmol/l

1.72

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

272

1484

1.86

20.13

1.7

1.5

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

189

912

2.10

19.92

1.2

1.3

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

160

730

2.21

19.45

1.3

5.9

4.2

nmol/l

0.12

154

706

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

179

855

2.12

19.39

1.3

269.2

279.9

u/ml

0.16

118

524

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

324

2.86

19.33

1.5

1.2

49.2

22.8

u/l

1.85

262

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

402

2483

1.65

19.25

2.4

2.2

7.5

7.4

g/l

0.26

285

1840

(3028192) IgG subclass 2 [Mass/volume] in Serum

124

509

2.46

19.22

1.3

2.6

2.9

g/l

1.17

353

(3024139) IgG subclass 3 [Mass/volume] in Serum

124

509

2.46

19.22

1.3

0.4

g/l

0.15

348

(3027135) IgG subclass 1 [Mass/volume] in Serum

124

510

2.45

19.14

1.3

7.0

6.8

g/l

0.15

351

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

339

2005

1.72

19.12

1.6

362.1

277.1

titre

0.15

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

149

665

2.26

19.11

1.3

—

(3040151) Glucose [Moles/volume] in Capillary blood

167

781

2.16

19.10

7.9

7.3

7.1

7.5

mmol/l

1.38

152

646

(4062490)

124

511

2.45

19.06

1.3

1.4

—

(3035637) Corticotropin [Mass/volume] in Plasma

152

685

2.24

19.05

1.5

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

400

2480

1.64

18.88

2.4

2.2

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

399

2474

1.64

18.83

2.4

2.2

3.9

g/l

0.13

275

1766

(3033799) Differential panel - Peritoneal fluid

186

3.46

18.56

2.2

1.9

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

154

3.72

18.42

1.3

1.2

—

(3002385) Erythrocyte distribution width [Ratio]

5472

50537

1.24

18.40

40.6

17.2

14.4

13.8

122.04

5389

49211

(3011985) Renin [Units/volume] in Plasma

157

735

2.16

17.94

1.6

1.4

63.3

57.2

mu/l

0.10

138

658

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

715

5091

1.44

17.84

4.1

2.7

62.2

62.0

ml/min/173m2

0.04

326

2039

(3048929) Epstein Barr virus Ab [Presence] in Serum

235

1273

1.87

17.83

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

122

4.03

17.75

1.6

1.2

—

(3037756) Immunofixation for Serum or Plasma

251

1393

1.83

17.63

1.5

1.6

—

(3023419) Bacteria identified in Sputum by Culture

165

793

2.10

17.63

3.0

2.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

372

2317

1.63

17.25

2.4

2.2

3.2

3.1

g/l

0.93

277

1805

(3008757) Leukocyte morphology finding [Identifier] in Blood

146

676

2.18

17.17

3.6

4.1

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

373

2330

1.63

17.10

2.4

2.2

10.2

10.3

g/l

0.16

300

1945

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

191

983

1.96

16.92

1.4

1.5

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

101

4.27

16.83

1.2

1.3

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

112

472

2.39

16.46

1.8

1.5

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

175

883

2.00

16.42

1.4

1.5

108.6

117.9

u/ml

0.52

186

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

140

650

2.17

16.37

1.3

—

nmol/l

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

360

2.60

16.36

1.9

1.5

6.3

6.0

u/l

0.06

159

(3003434) Protein [Mass/volume] in Pleural fluid

202

1073

1.90

16.31

1.4

1.5

32.6

31.7

g/l

0.40

181

947

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

130

3.78

16.29

1.2

—

(44790047)

142

667

2.15

16.13

1.9

1.4

—

(44790048)

142

667

2.15

16.13

1.9

1.4

—

(44806118)

142

667

2.15

16.13

1.9

1.4

—

(44790049)

142

667

2.15

16.13

1.9

1.4

—

(3043410) Blood group antigens tested for on Red Blood Cells

159

3.47

16.13

3.0

1.4

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

188

982

1.93

15.97

1.3

1.4

21.8

13.9

u/ml

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

114

496

2.32

15.61

2.0

1.6

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

135

632

2.15

15.49

2.8

3.4

62.8

58.9

1.14

394

(3010375) cycloSPORINE [Mass/volume] in Blood

230

2.97

15.44

25.6

25.5

118.9

112.4

ug/l

0.24

195

(3044242) Glucose [Moles/volume] in Arterial blood

348

2.57

15.37

3.6

2.0

—

(3023199) Leukocytes [#/volume] in Pleural fluid

180

940

1.93

15.32

1.5

1351.9

2215.9

e6/l

1.59

125

670

(3004451) EKG impression Narrative

337

2.60

15.31

1.3

1.2

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

167

851

1.98

15.26

1.4

1.5

29914.0

48685.6

e6/l

0.85

100

500

(36660697) Celiac disease serology panel - Serum

540

3762

1.46

15.09

1.2

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

101

423

2.40

15.09

1.6

1.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

207

3.06

15.05

5.0

2.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

207

3.06

15.05

5.0

2.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

272

1619

1.70

15.05

3.5

3.3

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

791

5904

1.37

14.97

1.9

1.7

1.6

1.5

2.81

654

5110

(3026493) Urate [Moles/volume] in Serum or Plasma

1974

16641

1.24

14.95

3.4

2.7

3259.5

5735.5

umol/l

2.32

1668

14184

(40761511) CBC panel - Blood by Automated count

6741

64205

1.27

14.90

31.7

13.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

238

1371

1.76

14.81

1.3

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

142

690

2.08

14.81

1.1

1.6

1.5

g/l

0.45

128

609

(3042631) Mycobacterium sp identified in Specimen

179

949

1.90

14.59

2.4

2.8

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

300

2.65

14.49

2.2

2.0

13.5

13.4

umol/l

0.01

207

(3012441) Differential panel - Pleural fluid

162

833

1.96

14.45

1.5

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

208

2.99

14.31

3.9

2.0

96.4

133.1

umol/l

0.66

110

(3045788) Cell count panel - Pleural fluid

147

739

2.01

14.00

1.5

1.6

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

259

1553

1.69

13.97

1.3

1.5

0.2

g/l

0.19

245

1457

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

140

696

2.03

13.76

1.3

388.2

271.1

pmol/l

0.57

105

528

(3041672) Baker's yeast Ab [Presence] in Serum

10.73

13.74

1.0

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4920

45544

1.20

13.68

4.2

3.8

14.9

15.0

pmol/l

0.53

4387

40747

(3028707) Methadone [Presence] in Urine by Screen method

107

482

2.23

13.56

2.9

2.7

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

6914

66217

1.26

13.52

39.2

16.8

83.3

80.8

umol/l

4.70

6909

66192

(3019225) pH of Specimen

835

6398

1.34

13.29

5.8

4.0

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

236

1400

1.70

13.27

1.3

1.1

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

6157

58288

1.22

13.12

31.3

13.6

77.4

76.5

ml/min/173m2

2.53

5462

47859

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

382

2.37

13.11

1.9

2.1

—

(3017732) Neutrophils [#/volume] in Blood

558

4016

1.42

13.08

4.1

3.0

4.3

4.2

e9/l

0.15

420

3005

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

262

1613

1.64

12.81

1.3

1.5

1.2

g/l

0.36

248

1514

(40768806) Pleura Pathology biopsy report

157

834

1.90

12.77

1.5

1.6

—

(3011412) CD3 cells [#/volume] in Blood

108

501

2.17

12.76

1.8

2.4

1.1

e9/l

0.09

321

(3017569) Oxygen content in Arterial blood

332

2.45

12.75

3.2

2.2

—

(3011648) Oxygen content in Venous blood

444

2.24

12.71

1.8

2.4

10.6

10.8

0.18

444

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

369

2.37

12.71

1.7

1.4

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

109

512

2.14

12.49

1.5

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

109

512

2.14

12.49

1.5

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

109

512

2.14

12.49

1.5

1.7

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

373

2.35

12.41

1.7

1.5

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

417

2.27

12.39

1.2

1.1

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6891

66114

1.25

12.36

19.2

10.0

25.2

26.1

u/l

3.04

6721

63141

(3010370) Gastrin [Moles/volume] in Serum or Plasma

4.54

12.32

2.0

1.7

85.6

47.0

pmol/l

0.43

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

125

624

2.02

12.20

1.6

1.7

—

(40757494) Bilirubin.total [Moles/volume] in Blood

352

2.37

12.15

3.1

2.3

17.3

38.1

umol/l

—

(21494755) Public health laboratory ask at order entry panel

254

3985

0.63

12.12

1.2

1.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

190

2.91

12.12

1.2

1.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

190

1090

1.76

12.07

1.4

1.5

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

190

1093

1.75

11.96

1.4

11.7

10.3

u/l

0.71

161

879

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

135

3.27

11.85

1.9

2.5

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

155

853

1.83

11.34

1.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

134

705

1.91

11.28

1.3

1.4

6.1

6.4

mmol/l

0.72

121

646

(3016650) Hepatitis A virus Ab [Presence] in Serum

155

855

1.83

11.26

1.1

—

(3009542) Hematocrit [Volume Fraction] of Blood

5799

54854

1.19

11.26

34.1

15.4

37.2

39.4

41.55

3526

36580

(3021788) Differential panel - Synovial fluid

183

1068

1.73

10.99

1.5

1.4

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

320

2.35

10.87

1.7

2.8

545.9

522.2

e6/l

0.15

269

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

118

3.31

10.77

3.1

2.9

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

190

1128

1.70

10.74

3.3

3.1

—

(4198724)

145

3.04

10.57

1.5

2.9

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

140

3.08

10.54

2.2

1.3

15.6

13.3

g/l

1.00

113

(3022621) pH of Urine by Test strip

546

4061

1.37

10.54

4.0

2.9

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

382

2.21

10.51

1.3

1.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

120

3.26

10.49

1.4

1.2

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

199

1206

1.67

10.42

1.4

8.1

26.5

e6/l

2.03

158

926

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

114

585

1.96

10.36

1.6

1.7

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

199

1208

1.66

10.36

1.4

1.5

740.9

1214.9

e6/l

0.62

168

987

(3006576) Bicarbonate [Moles/volume] in Blood

232

2.55

10.21

6.2

25.8

24.6

mmol/l

0.79

209

(3045716) Anion gap in Serum or Plasma

311

2.33

10.18

1.8

2.4

9.3

9.4

mmol/l

0.07

242

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

159

2673

0.59

10.13

1.4

1.5

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

395

2.16

10.10

1.8

2.2

14.5

13.6

0.20

158

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

306

2.33

10.09

1.8

2.8

0.2

e9/l

0.01

267

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

314

2136

1.49

9.97

2.3

0.9

1.0

g/l

0.07

268

1796

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

277

4088

0.67

9.94

1.7

1.8

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

291

1951

1.51

9.92

2.1

36.5

37.4

g/l

1.24

245

1654

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

298

2.33

9.78

2.5

2.4

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

414

2.11

9.74

1.2

129.2

151.2

titre

0.15

(3000475) Leukocytes [#/volume] in Synovial fluid

225

1432

1.59

9.70

1.6

14847.2

14346.6

e6/l

0.05

162

1021

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

293

2.33

9.69

1.1

1.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

166

981

1.71

9.59

1.3

1.4

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

437

2.07

9.57

1.5

1.3

promille

0.05

332

(3001893) Eosinophils/100 leukocytes in Pleural fluid

240

2.47

9.54

1.3

1.4

1.7

2.9

0.60

204

(3032057) Clostridioides difficile [Presence] in Stool

113

3.19

9.41

2.1

1.9

—

(1761482) Bacteria [#/volume] in Urine by Culture

277

1860

1.51

9.39

6.2

3.9

—

(3005322) IgE [Units/volume] in Serum or Plasma

413

3005

1.39

9.14

1.4

1.3

165.7

267.4

u/ml

2.33

388

2763

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

5785

60433

0.86

9.09

4.4

1.4

mmol/l

2.31

5167

54756

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

328

2.20

9.03

1.9

2.9

2.1

u/field

0.56

228

(3027570) Oxalate [Moles/time] in 24 hour Urine

6.26

8.98

1.3

449.9

314.3

umol/24h

0.64

(3006922) Hepatitis E virus Ab [Presence] in Serum

330

2.19

8.90

1.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

276

1874

1.49

8.89

2.2

2.1

0.0

g/l

0.17

250

1688

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

172

2.68

8.85

1.7

2.4

32.2

30.7

0.22

161

(3000330) Specific gravity of Urine by Test strip

449

3331

1.37

8.84

5.4

3.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

259

1739

1.50

8.81

1.7

1.6

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

301

2083

1.46

8.81

1.1

1.0

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

127

714

1.79

8.77

1.3

370.4

383.8

u/l

0.07

116

676

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

192

1207

1.60

8.76

1.1

1.0

10.6

u/ml

3.81

125

(3014271) Vancomycin [Susceptibility]

379

2.09

8.71

3.9

2.9

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

308

2.22

8.66

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

309

2.21

8.60

1.1

1.0

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

248

1661

1.51

8.55

1.4

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

291

2.24

8.52

1.5

2.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

291

2.24

8.52

1.5

2.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

291

2.24

8.52

1.5

2.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

291

2.24

8.52

1.5

2.0

—

(3028717) Thiamine [Mass/volume] in Blood

4.04

8.50

1.1

1.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

111

606

1.84

8.45

1.2

1.1

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

287

1988

1.46

8.38

1.1

9.1

u/ml

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

335

2389

1.42

8.36

1.6

1.8

38.7

38.6

u/l

0.04

291

2049

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

257

1746

1.49

8.28

2.2

2.1

0.0

g/l

0.79

232

1567

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

190

1210

1.58

8.24

1.3

3.8

3.9

mmol/l

0.38

173

1131

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1005

8360

1.23

8.16

15.0

7.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

5.01

8.12

1.1

—

(1761868) Lipid panel - Serum or Plasma

1771

20058

0.85

8.12

3.1

3.0

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

210

1374

1.54

8.09

1.3

534.4

570.9

mg/l

0.40

200

1299

(3044941) Cell count panel - Synovial fluid

148

891

1.67

8.05

1.5

1.4

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

211

2.42

8.02

1.2

1.5

23.7

18.4

0.67

195

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

164

2.63

7.99

1.3

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

147

886

1.67

7.97

1.4

1.3

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

251

1713

1.48

7.93

2.2

2.1

0.0

g/l

0.00

230

1563

(3035947) Staphylolysin Ab [Units/volume] in Serum

276

2.22

7.83

1.2

1.1

4.7

3.5

iu/ml

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

289

2.19

7.82

1.3

1.4

62.9

66.2

0.30

237

(3020393) Adenovirus Ag [Presence] in Stool

4.04

7.78

1.2

1.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

149

914

1.64

7.57

1.2

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

100

549

1.83

7.53

1.2

1.3

17.0

12.2

u/l

0.56

504

(3042517) Benzodiazepines panel - Urine

5.60

7.53

2.4

1.8

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

280

1972

1.43

7.52

1.2

1.1

1.4

u/ml

0.08

183

(21494890) Protein electrophoresis panel - 24 hour Urine

117

675

1.74

7.47

1.8

2.1

—

(3045142) Bone marrow Pathology biopsy report

120

699

1.73

7.41

1.3

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

5870

60985

0.87

7.39

4.5

4.4

4.6

mmol/l

32.70

5286

55619

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

293

2.12

7.18

2.7

2.8

37.0

38.4

0.16

100

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

438

1.90

7.09

1.3

1.2

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

303

2.09

6.99

1.3

1.1

32.6

27.1

u/l

0.20

210

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

304

2.08

6.93

1.3

1.1

92.0

90.9

u/l

0.02

220

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

222

1521

1.47

6.93

1.2

1.3

—

(3044290) Cell count panel - Cerebral spinal fluid

170

1103

1.55

6.87

1.4

—

(3026389) Candida sp identified in Specimen by Organism specific culture

125

756

1.66

6.76

1.3

—

(3013336) Amino acids [Identifier] in Serum or Plasma

16.68

6.73

2.9

4.2

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

349

1.98

6.69

2.0

2.7

666.0

640.6

e6/l

0.09

135

(3006270) Folate [Moles/volume] in Blood

541

1.78

6.69

1.2

338.8

346.3

nmol/l

0.13

430

(3045414) Leukocytes [Presence] in Urine

355

2668

1.34

6.51

2.4

1.9

—

(3036071) Salmonella sp Ab [Titer] in Serum

129

2.64

6.45

1.0

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

136

854

1.60

6.36

1.7

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

275

2.08

6.31

1.3

1.8

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

275

2.08

6.31

1.3

1.8

—

(3035880) pH of Pleural fluid

408

1.87

6.22

1.3

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

345

1.95

6.21

3.4

4.0

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

311

2.00

6.19

1.3

1.1

1.2

nmol/l

0.14

240

(3010144) Erythrocytes [#/volume] in Synovial fluid

563

1.73

6.14

1.3

1.4

140552.6

173901.8

e6/l

0.16

381

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

6048

62480

0.88

6.08

4.9

5.0

2.5

2.7

mmol/l

50.28

5416

56691

(3016244) Insulin [Units/volume] in Serum or Plasma

233

2.15

6.06

2.3

3.3

24.3

22.6

mu/l

0.13

223

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

100

588

1.71

6.05

1.6

1.5

29.4

28.2

0.13

359

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

106

634

1.68

6.02

4.0

3.5

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

195

2.26

6.02

2.3

1.8

3404.5

75545.4

u/ml

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

136

866

1.58

6.02

1.1

—

(4010399)

527

4226

1.26

5.98

1.5

1.4

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

129

2.56

5.93

1.2

1.1

98.7

84.0

1.71

(1001926) Buprenorphine [Presence] in Urine by Screen method

135

863

1.57

5.89

2.7

2.1

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

166

2.35

5.86

2.5

2.4

131.4

149.7

nmol/l

0.74

142

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.29

5.84

1.8

1.9

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

5.50

5.80

1.7

1.6

2.2

2.1

mg/l

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

5.50

5.80

1.5

2.4

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

5.50

5.80

1.7

1.6

0.2

2.2

mg/l

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

5.50

5.80

1.7

1.6

0.5

1.1

mg/l

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

5.50

5.80

1.7

1.6

0.3

2.5

mg/l

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

5.50

5.80

1.7

1.6

0.6

1.8

mg/l

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

5.50

5.80

1.1

1.3

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

3.00

5.78

16.1

11.1

5.3

5.5

mmol/l

0.15

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

238

2.11

5.76

3.0

2.4

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

4.65

5.72

5.2

7.4

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

569

1.69

5.67

1.9

2.1

2.3

1.9

u/field

0.38

207

(21494815) CD4 cells/100 lymphocytes in Specimen

451

1.78

5.63

1.8

2.4

30.4

39.6

—

(3042733) HLA Ab [Presence] in Serum

145

2.42

5.59

4.3

4.7

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

127

2.52

5.59

1.2

102.5

84.5

1.57

(3023410) Appearance of Cerebral spinal fluid

504

1.73

5.58

1.6

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

2.80

5.55

1.2

78.3

76.8

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

5.24

5.51

1.7

1.6

1.1

2.0

mg/l

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

5815

56037

1.12

5.51

5.1

4.5

2.1

2.2

mu/l

0.13

5200

50366

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

304

1.95

5.50

1.0

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

117

740

1.59

5.38

1.2

3.6

3.7

u/ml

0.02

229

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.09

5.32

1.8

1.9

—

(3007461) Platelets [#/volume] in Blood

7037

68697

1.16

5.31

49.1

20.7

256.8

244.2

e9/l

35.19

6900

66449

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

253

2.02

5.30

1.2

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

156

2.31

5.23

1.6

1.3

153.9

128.5

nmol/l

0.32

114

(3045424) Erythrocytes [Presence] in Urine

149

1001

1.50

5.23

1.8

1.5

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

212

1523

1.40

5.22

1.7

1.9

11.6

11.7

mg/l

0.08

188

1412

(3035941) MCH [Entitic mass]

7038

68724

1.16

5.22

48.9

20.6

30.2

30.4

19.97

6941

67377

(3024731) MCV [Entitic volume]

7038

68730

1.16

5.19

49.0

20.6

91.3

91.4

0.87

6942

67384

(3026361) Erythrocytes [#/volume] in Blood

7038

68733

1.16

5.17

49.1

20.7

4.3

4.5

e12/l

194.83

6877

66244

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

858

7341

1.19

5.17

1.5

1.4

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.34

5.15

1.2

1.3

—

(3016879) Cocaine [Presence] in Urine

152

1030

1.48

5.13

2.8

2.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1469

16378

0.87

5.09

1.8

1.6

1.5

1.4

mmol/l

4.71

1199

13493

(3000963) Hemoglobin [Mass/volume] in Blood

7038

68747

1.15

5.09

49.5

20.8

127.0

135.1

g/l

300.16

6944

67403

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

2.72

5.08

1.1

1.2

98.7

80.7

—

(3010813) Leukocytes [#/volume] in Blood

7038

68753

1.15

5.06

49.2

20.7

7.2

6.8

e9/l

26.25

6880

66260

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

372

1.81

5.01

1.1

1.0

288.9

289.4

mg/l

0.02

335

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

155

1061

1.47

4.98

1.2

1.3

191.1

219.6

miu/ml

0.36

452

(3001964) Herpes simplex virus Ag [Presence] in Specimen

166

2.23

4.98

1.6

1.4

—

(3025315) Body weight

3.89

4.97

5.5

3.9

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

115

740

1.56

4.94

1.7

1.5

61.7

0.00

442

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

233

2.02

4.92

1.4

2.3

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

213

2.07

4.91

1.7

1.3

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

220

1609

1.38

4.90

1.5

1.8

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

113

726

1.56

4.90

1.3

1.2

4.4

4.5

u/ml

0.05

302

(3021387) Prolactin [Units/volume] in Serum or Plasma

170

1190

1.44

4.87

1.9

1.7

366.0

311.6

mu/l

0.56

159

1096

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

2.92

4.86

1.8

2.9

62.5

31.1

mg/l

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.82

4.80

4.4

5.0

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

520

1.66

4.78

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

119

2.44

4.77

1.9

2.5

1201.1

1231.7

e6/l

0.01

(3012565) Volume of 24 hour Urine

306

1.87

4.76

1.9

2.3

1994.5

1924.4

0.11

262

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

230

2.00

4.72

1.4

2.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

230

2.00

4.72

1.4

2.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

507

1.66

4.71

1.2

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

141

959

1.48

4.70

1.2

—

(3011288) Drugs identified in Urine by Screen method

108

694

1.56

4.69

3.9

3.2

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

512

1.65

4.55

1.1

90.9

96.3

0.98

476

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1036

9105

1.16

4.47

1.3

32.5

39.2

iu/ml

0.67

328

2828

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

111

2.44

4.45

1.3

1.4

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

406

3278

1.25

4.42

3.1

3.3

4.3

4.4

pmol/l

1.99

349

2866

(4306422)

108

707

1.53

4.35

1.2

—

(3027008) Opiates [Presence] in Urine

158

1118

1.42

4.32

2.8

1.9

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

543

1.61

4.31

1.4

—

(3009508) Creatinine [Moles/volume] in Urine

2238

20684

1.11

4.30

3.3

3.1

7.3

7.5

mmol/l

0.86

1863

17101

(3000764) Benzodiazepines [Presence] in Urine

157

1111

1.42

4.29

2.8

2.1

—

(3046861) Legionella sp Ag [Presence] in Urine

3.87

4.25

1.3

1.0

—

(3028300) Cannabinoids [Presence] in Urine

158

1122

1.42

4.24

2.8

2.0

—

(3002619) Bacteria identified in Specimen by Culture

120

2.34

4.23

1.3

1.2

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

6.92

4.15

1.4

1.5

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

105

691

1.53

4.15

1.1

116.3

115.7

0.05

605

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

572

1.58

4.15

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

410

1.69

4.15

3.0

2.4

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

160

2.13

4.13

1.6

1.7

10.1

9.0

ug/l

0.51

160

(3023323) Follitropin [Units/volume] in Serum or Plasma

198

1470

1.35

4.08

1.5

1.3

29.4

32.1

iu/l

0.52

173

1256

(3023511) Choriogonadotropin [Units/volume] in Urine

367

1.72

4.07

1.6

1.2

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

2.86

4.05

1.4

1.8

1.2

1.5

mmol/l

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

117

2.31

3.99

4.7

5.8

64.2

45.3

u/l

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

111

2.35

3.98

1.1

1.2

—

(3027944) Amphetamines [Presence] in Urine

153

1094

1.41

3.97

2.8

2.0

—

(3036603) Volume of Urine

408

1.67

3.96

1.6

2060.8

1924.1

0.46

104

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

2.53

3.95

1.1

1.3

99.2

171.1

ng/l

0.40

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

487

1.61

3.90

2.1

1.8

4.5

4.2

mg/l

0.28

465

(21494434) Karyotype in Bone marrow

535

1.58

3.87

1.1

1.2

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

119

2.27

3.85

1.4

10.5

11.0

0.04

(4268621)

482

1.60

3.81

2.2

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

3.06

3.79

1.7

48.9

46.2

umol/l

0.13

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

222

1.90

3.75

2.6

2.9

29.0

29.1

umol/l

0.01

164

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.73

3.74

1.3

1.2

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

273

1.80

3.72

1.3

1.2

46.0

59.1

—

(44786800) Granulocytes/100 leukocytes in Body fluid

2.40

3.71

1.3

30.0

20.0

0.52

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

455

1.61

3.69

1.2

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.79

3.68

2.2

2.1

15.7

19.1

umol/l

0.58

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

260

1.81

3.66

1.3

1.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.69

3.64

2.9

1.8

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

204

1.92

3.60

1.2

1.4

56.5

59.8

0.21

171

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

136

2.14

3.59

3.2

2.8

7.0

7.8

mmol/l

0.50

(3027456) Digoxin [Moles/volume] in Serum or Plasma

206

1571

1.32

3.59

3.6

3.0

0.8

nmol/l

0.37

164

1236

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1311

14424

0.89

3.58

2.9

3.1

0.8

ug/l

0.24

900

9940

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

168

1246

1.35

3.54

1.2

1.1

—

(40757373) Influenza virus identified in Isolate

124

2.18

3.52

1.9

1.6

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.47

3.45

2.2

1.8

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

440

1.60

3.45

1.2

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

159

2.02

3.43

6.5

8.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

153

1125

1.37

3.42

1.2

2.5

4.9

u/ml

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

142

1036

1.38

3.34

1.2

1.3

25.5

39.1

u/l

1.86

124

885

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

203

1.87

3.32

1.9

1.8

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.71

3.31

1.1

1.0

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

299

1.71

3.29

1.0

1.1

—

(3017704) Immunofixation for Urine

360

1.64

3.29

2.0

1.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

470

1.56

3.27

1.7

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

566

1.51

3.27

1.6

1.4

—

(3012516) Albumin [Mass/volume] in Urine

2145

20030

1.09

3.21

3.4

3.2

894.9

344.1

mg/l

3.42

1455

12679

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

171

1294

1.33

3.19

1.4

1.3

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

302

1.69

3.19

1.7

1.4

3.4

1.29

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

473

1.55

3.19

2.3

2.4

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

3.33

3.18

1.1

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

458

1.55

3.16

1.3

1.5

0.3

nmol/l

0.23

343

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

177

1354

1.31

3.08

1.2

8.3

6.8

u/ml

0.09

224

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

175

1337

1.31

3.07

1.2

17.5

4.0

u/ml

0.41

149

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

187

1447

1.30

3.00

1.2

8.7

41.7

u/ml

—

(3020682) Albumin/Creatinine [Ratio] in Urine

2254

21163

1.09

2.95

4.1

3.9

13.2

9.2

mg/mmol

2.78

1473

13326

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.54

2.94

1.1

1.3

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

148

1.96

2.93

2.7

2.0

1.2

ug/l

0.11

143

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

227

1.76

2.93

1.5

1.7

3.8

4.5

nmol/l

0.21

193

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

656

1.44

2.90

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

3.33

2.90

1.2

1.3

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

288

1.67

2.89

1.1

1.2

1.0

1.1

ratio

0.19

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

5696

58323

0.92

2.84

4.1

4.0

1.4

1.3

mmol/l

10.63

5082

52373

(3038071) Oxygen [Partial pressure] in Mixed venous blood

136

1.99

2.84

6.1

8.0

—

(3000492) Spirometry study

586

5118

1.16

2.82

1.5

1.4

—

(21494814) CD8 cells/100 lymphocytes in Specimen

230

1.74

2.81

1.9

2.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

116

2.07

2.81

1.8

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

335

2794

1.21

2.80

1.9

1.8

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

2.17

2.76

1.5

3.2

110.0

106.2

ng/l

—

(40768795) Lymph node Pathology biopsy report

666

1.42

2.70

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

102

734

1.39

2.68

1.3

1.2

—

(3028433) Virus identified in Specimen by Culture

197

1.78

2.66

1.1

—

(3014891) Appearance of Pleural fluid

126

1.99

2.64

1.8

1.4

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.33

2.64

1.1

1.0

—

(3044927) Protein electrophoresis panel - Urine

669

1.41

2.64

1.2

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

140

1.93

2.64

1.3

1.2

1.6

1.5

mmol/l

0.20

(3014051) Protein [Presence] in Urine by Test strip

174

1361

1.28

2.62

2.9

2.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

101

732

1.38

2.56

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

207

1.74

2.56

1.1

1.0

—

(3049242) von Willebrand panel - Platelet poor plasma

5.45

2.54

1.7

1.6

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.73

2.54

1.1

1.0

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

135

1.93

2.54

1.8

1.5

0.5

0.4

ug/l

0.24

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

165

1.82

2.47

1.0

1.1

—

(3020491) Glucose [Moles/volume] in Blood

437

1.49

2.47

1.9

2.1

7.9

7.1

mmol/l

0.84

300

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

365

3109

1.18

2.46

1.9

1.8

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.67

2.44

1.0

5.6

18.2

u/l

1.34

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

159

1.83

2.42

1.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

540

1.43

2.38

1.0

1.1

—

53.8

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.34

2.38

1.2

1.0

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

4.12

2.35

1.0

1.4

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

168

1.79

2.35

1.4

1.2

0.3

g/l

0.81

133

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

945

8611

1.11

2.34

1.3

1.2

12.3

14.3

u/ml

0.34

345

3221

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.04

2.30

1.1

1.2

0.7

umol/24h

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

185

1.73

2.27

1.0

1.1

—

(40768800) Prostate Pathology biopsy report

128

1652

0.77

2.27

1.2

—

(3030313) Adrenal Ab [Titer] in Serum

3.48

2.26

1.0

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

120

1.92

2.24

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

505

1.43

2.24

1.8

1.6

23.1

25.8

u/ml

0.22

110

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.27

2.23

1.1

1.0

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

677

0.65

2.21

1.2

7.3

7.7

mmol/l

0.35

492

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

735

1.35

2.21

2.3

2.0

24.4

26.6

mg/l

0.18

198

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

5.55

2.21

1.4

1.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

482

1.43

2.20

1.0

1.1

—

(3024263) Appearance of Synovial fluid

335

1.52

2.20

1.5

1.6

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

583

1.39

2.19

1.0

1.1

1.8

3.7

u/ml

1.78

257

(3036670) Protein [Mass/volume] in Synovial fluid

188

1.70

2.16

1.3

1.2

36.8

40.1

g/l

0.54

(1002224) Polysomnography panel

156

1951

0.80

2.15

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

163

1303

1.26

2.12

1.3

1.7

3.3

4.8

iu/l

1.61

441

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.05

2.10

1.1

—

(3000012) Reticulocyte production index

421

1.45

2.09

1.6

1.5

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

691

1.35

2.09

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

137

1732

0.79

2.08

1.6

1.7

3.0

3.5

mg/l

0.41

1240

(3047007) Chlamydophila sp Ab [Presence] in Serum

640

1.36

2.08

1.3

1.2

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

4.00

2.03

1.0

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

443

0.59

2.03

1.0

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

567

1.38

2.02

1.0

1.1

—

3.0

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

147

1170

1.26

2.00

3.4

1.7

0.8

nmol/l

0.01

127

987

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

327

1.50

1.99

1.1

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.14

1.97

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

3.33

1.96

1.0

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

119

1.85

1.96

1.1

1.2

334.2

280.0

pmol/l

0.29

(3009871) Measles virus Ab [Titer] in Serum

134

1.79

1.94

1.5

1.7

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

234

1.58

1.92

1.1

1.0

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

106

1.89

1.90

1.2

1.5

65.7

112.5

ug/l

1.87

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.92

1.89

2.3

1.7

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

143

1.75

1.88

1.8

3.3

—

(3039443) Prostate specific Ag panel - Serum or Plasma

1190

0.76

1.84

1.7

1.6

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

190

1578

1.21

1.78

2.0

1.7

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

116

1.81

1.77

1.5

1.6

178.3

125.3

ng/l

0.50

116

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

184

1.63

1.77

1.4

15.7

22.9

0.91

150

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

128

1020

1.26

1.77

1.2

44.5

46.4

u/ml

0.05

103

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.09

1.75

1.4

1.5

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

224

1.56

1.75

1.2

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

217

1.57

1.72

1.1

1.3

305.4

238.6

ug/l

0.14

124

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.67

1.72

1.1

1.2

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.92

1.72

1.1

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

3.85

1.71

1.0

2.0

3.2

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

125

1.76

1.71

1.2

1.3

1.2

89.0

mg/l

1.00

(3051387) C reactive protein [Mass/volume] in Capillary blood

184

1534

1.20

1.68

5.4

3.4

27.8

29.8

mg/l

0.31

130

1014

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

3.16

1.66

7.8

3.6

—

(40768443) Skin Pathology biopsy report

307

2675

1.15

1.65

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

313

3572

0.87

1.64

1.4

1.3

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

228

1.54

1.64

1.2

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

616

1.32

1.63

1.2

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

3.00

1.58

1.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

177

1481

1.20

1.57

1.9

1.8

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

235

0.51

1.56

1.3

1.4

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

330

1.43

1.55

1.1

0.7

6.1

nmol/l

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

297

1.45

1.54

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

281

1.46

1.53

1.1

6.4

12.3

iu/ml

1.40

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

3.33

1.52

1.0

1.1

—

mmol/l

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

321

0.59

1.51

1.2

1.3

—

1.5

—

(3000285) Sodium [Moles/volume] in Blood

1.83

1.51

1.1

1.2

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

123

1.71

1.50

2.4

1.7

3.3

2.2

ug/l

0.43

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

548

6007

0.91

1.48

1.5

1.6

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

401

1.37

1.48

2.7

1.9

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

383

3418

1.13

1.47

1.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.22

1.46

1.3

1.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

2.37

1.45

1.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

3.12

1.43

1.2

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

110

1.73

1.42

1.1

—

(4024509)

631

1.29

1.40

2.0

1.5

—

(40768446) Kidney Pathology biopsy report

197

1.52

1.39

1.9

1.6

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

134

1.64

1.38

1.0

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

347

1.38

1.37

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

347

1.38

1.37

1.1

—

(4034850)

236

2052

1.15

1.36

16.3

10.4

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

239

1.47

1.36

1.1

1.6

4.4

ug/l

1.49

183

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

348

1.38

1.35

1.1

—

(3003338) MCHC [Mass/volume]

5205

51088

1.05

1.35

44.2

18.4

330.1

332.1

g/l

44.47

5147

50578

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

207

1.50

1.34

1.0

1.1

1689.6

1517.6

miu/ml

0.30

207

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

140

1168

1.20

1.33

1.9

1.8

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.91

1.33

1.8

1.5

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

1.91

1.33

1.5

1.1

45.4

115.0

ug/l

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

2.50

1.30

3.7

11.5

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

507

1.30

1.29

1.3

35.1

30.1

u/l

0.60

421

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.35

1.29

1.0

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

352

1.37

1.28

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

352

1.37

1.28

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

352

1.37

1.28

1.1

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

456

1.32

1.27

1.4

1.3

122.9

350.4

titre

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.94

1.27

2.5

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

365

0.66

1.26

6.8

6.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

285

1.40

1.26

1.4

1.5

—

(3004616) Nuclear Ab [Presence] in Serum

678

1.26

1.25

1.2

1.3

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

375

0.67

1.24

1.4

1.5

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

261

1.42

1.24

1.3

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.86

1.23

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.63

1.21

3.8

1.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

117

1403

0.83

1.21

1.3

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

148

1.55

1.19

1.0

1.1

—

(3020650) Glucose [Presence] in Urine

148

1.55

1.19

1.8

1.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

497

4558

1.10

1.19

2.4

2.1

12.4

nmol/l

0.00

432

4010

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

1.93

1.16

1.1

1.0

113.1

79.1

ug/l

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.50

1.15

1.0

1.4

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.50

1.15

1.2

1.1

169.6

259.7

nmol/l

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.00

1.12

1.0

1.1

—

(4015189)

167

1.50

1.11

2.6

2.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

111

1.62

1.11

5.8

7.3

—

(3024471) HLA-A [Type]

159

1.51

1.11

1.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.26

1.10

1.0

1.5

—

(44813793)

312

1.35

1.07

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

550

1.26

1.06

1.4

1.3

1.4

1.5

nmol/l

0.01

487

(3029075) Extractable nuclear Ab panel - Serum

145

1.52

1.05

1.0

—

(3006462) Nitrate [Presence] in Urine

280

1.36

1.03

2.7

3.3

—

(3008536) Aspergillus sp Ab [Presence] in Serum

122

1.56

1.02

1.4

2.2

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

275

0.65

1.01

1.3

1.5

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

645

1.23

1.00

2.0

1.9

—

3.4

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.00

1.00

3.3

2.7

—

(3047189) Immunofixation for 24 hour Urine

317

1.33

0.98

1.6

1.7

—

(3024932) HLA-DR beta [Type]

156

1.47

0.98

1.0

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

156

1.47

0.98

1.0

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.94

0.97

1.0

1.1

—

(4027681)

276

1.34

0.94

1.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

302

1.33

0.94

1.5

1.4

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

478

0.75

0.94

4.6

5.2

16.2

82.0

u/ml

—

143

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.89

0.94

1.0

1.1

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.22

0.93

1.0

1.6

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

312

1.31

0.92

1.4

1.5

5.4

6.9

u/l

1.11

258

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2591

25207

1.04

0.92

4.8

5.0

3.1

3.7

ug/l

1.00

2261

22438

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

190

1687

1.13

0.89

2.0

2.3

187.5

114.1

ug/min

0.74

109

980

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

642

6820

0.94

0.89

1.4

—

(4211845)

314

1.31

0.89

2.9

3.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

748

7903

0.94

0.88

4.4

4.6

33.5

32.7

0.97

514

5218

(3022475) Manganese [Moles/volume] in Blood

2.00

0.87

1.7

1.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

136

1.47

0.86

1.0

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

136

1.47

0.86

1.1

1.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

186

2078

0.89

0.82

1.9

1.7

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.74

0.82

1.1

2.0

—

(3023420) DNA double strand Ab [Units/volume] in Serum

534

1.22

0.81

1.3

—

23.9

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

240

1.33

0.81

3.2

2.3

66.0

55.9

umol/l

0.72

192

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

350

3228

1.09

0.81

1.2

1.3

43.5

52.8

au/ml

0.30

151

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.64

0.81

1.2

1.1

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

271

0.70

0.80

1.3

6.2

6.1

mmol/l

0.15

255

(3008898) HLA-B27 [Presence]

164

1457

1.13

0.79

1.1

—

(3025130) Human papilloma virus identified in Specimen

509

1.22

0.79

1.6

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1965

20214

0.96

0.78

4.2

4.4

21.8

22.2

0.62

962

10436

(3050794) Legionella sp Ab [Presence] in Serum

1.67

0.78

1.1

—

(40765096) Chromosome analysis panel by Banding

190

1.37

0.78

1.0

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

385

3575

1.08

0.77

2.3

2.4

61.1

24.3

au/ml

1.49

166

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

347

3209

1.08

0.77

1.1

1.2

107.7

138.2

iu/ml

0.90

106

1167

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

287

1.29

0.76

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

5751

58072

0.97

0.75

6.6

6.0

40.6

40.5

mmol/mol

0.27

5233

52919

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

167

1.38

0.73

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.79

0.72

1.7

1.5

—

(3020874) Milk IgE Ab [Units/volume] in Serum

211

1.33

0.71

1.0

1.1

1.3

u/ml

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.58

0.71

24.7

8.9

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.58

0.71

2.8

0.8

0.4

u/field

0.43

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

362

1.24

0.71

1.2

1.3

0.5

1.3

u/ml

0.68

177

(3026470) Cobalt [Mass/volume] in Blood

471

1.21

0.70

1.9

5.3

3.6

ug/l

0.50

418

(3001729) Color of Synovial fluid

1.55

0.69

1.1

1.5

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

127

1.42

0.67

2.2

3.4

—

(3016750) Collection duration of Urine

383

1.23

0.67

1.8

2.1

491.1

495.1

min

0.07

260

(3019174) dRVVT (LA screen)

1.63

0.66

1.0

1.3

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.72

0.64

12.8

8.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

155

1.36

0.62

1.0

1.1

—

(3025549) Creatine [Moles/time] in 24 hour Urine

1.63

0.62

1.6

1.3

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

1.59

0.61

1.0

13.4

9.4

iu/ml

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.60

0.61

1.4

2.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

130

1.38

0.61

1.1

1.4

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.60

0.0

1.0

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.57

0.60

1.1

1.3

1.7

1.8

umol/24h

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.60

0.0

1.0

—

8.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

122

1.39

0.59

1.4

1.6

—

(4133840)

140

1.36

0.58

1.3

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

343

0.79

0.58

1.4

1.7

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.48

0.57

1.6

2.8

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.48

0.57

2.8

4.5

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

220

1.27

0.56

1.1

101.8

95.3

0.58

164

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.50

0.54

1.0

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.54

0.53

1.0

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

304

1.22

0.52

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.41

0.51

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

659

1.14

0.50

2.7

3.1

33.7

57.3

mg/l

0.57

489

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

417

1.18

0.49

1.6

1.7

—

(21491868) Cryoglobulin [Mass/volume] in Serum

207

1.26

0.49

1.0

1.1

—

0.3

g/l

—

(3025577) Chromium [Mass/volume] in Blood

465

1.16

0.47

2.1

2.0

2.5

2.4

ug/l

0.07

389

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

120

1.33

0.46

1.1

—

(44806420)

232

0.77

0.46

2.0

2.4

—

(3051101) Glucose [Moles/volume] in Cord blood

147

1.29

0.45

3.4

7.0

—

(3017509) Phencyclidine [Presence] in Urine

1.61

0.43

1.4

1.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

806

0.89

0.41

1.4

1.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

341

1.17

0.41

1.0

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.35

0.41

1.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

498

0.86

0.41

1.5

1.4

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.40

0.0

1.1

—

(3013762) Body weight Measured

0.00

0.40

0.0

1.3

—

(3051593) INR in Capillary blood by Coagulation assay

352

1.16

0.39

11.9

12.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

6040

60725

0.98

0.39

4.9

4.7

6.1

6.0

mmol/l

1.81

5400

54425

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.39

0.0

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

205

1.22

0.39

1.0

1.1

0.7

2.2

u/ml

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.39

0.38

1.2

1.1

—

(3004775) Volume in Urine collected for unspecified duration

561

1.12

0.37

1.8

2.2

724.6

628.1

0.80

350

(3012494) Peanut IgE Ab [Units/volume] in Serum

116

1.29

0.36

1.1

0.4

1.5

u/ml

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.39

0.36

1.7

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.29

0.36

1.0

1.1

—

(3034426) Prothrombin time (PT)

171

1.23

0.35

1.1

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.37

0.34

1.3

1.6

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.33

0.33

1.3

1.0

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

1.33

0.33

1.0

1.1

—

3.9

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

633

1.11

0.33

1.1

4.3

u/ml

4.24

315

(3036048) Francisella tularensis Ab [Titer] in Serum

127

1.26

0.33

1.0

1.1

—

626.7

—

(3048879) Bone marrow aspiration report

191

1.20

0.33

1.3

1.9

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

350

1.14

0.32

1.8

2.2

145.0

177.5

ug/min

0.13

(3024869) Neuronal Ab [Presence] in Serum

119

1.26

0.31

1.0

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

276

2637

1.05

0.31

1.6

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

100

0.70

0.30

1.3

1.5

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.31

0.30

1.3

1.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

111

1.26

0.29

1.1

1.2

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

109

0.73

0.29

1.0

—

5.8

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.32

0.28

1.3

1.6

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

327

1.13

0.27

1.4

1.5

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

406

0.89

0.27

1.5

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

406

0.89

0.27

1.5

1.4

—

(3035933) Granulocytes/100 leukocytes in Blood

128

0.78

0.26

1.1

1.4

—

(3027035) Albumin [Mass/time] in 24 hour Urine

1.21

0.26

1.1

1.3

—

692.7

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.21

0.26

1.0

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

159

1.19

0.26

1.0

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

124

1166

1.06

0.26

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

405

0.89

0.26

1.5

1.4

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

160

0.81

0.26

1.2

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

424

1.11

0.25

1.2

1.3

10.1

11.6

mmol/l

0.77

118

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

404

0.89

0.25

1.5

1.4

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

197

1.17

0.25

1.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

213

0.84

0.25

1.2

1.4

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

151

1.19

0.25

1.4

1.9

—

(3022689) Creatine [Moles/volume] in Urine

180

1.17

0.23

2.1

1.4

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

190

0.84

0.23

1.2

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.32

0.23

1.0

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

1.19

0.21

1.2

1.4

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.21

0.0

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

613

1.08

0.21

1.1

0.2

1.2

u/ml

2.48

267

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.24

0.20

1.0

1.2

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.22

0.20

1.3

1.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.20

0.19

1.0

1.8

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

155

1.16

0.19

1.0

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

270

0.89

0.19

1.1

0.9

1.1

u/l

—

138

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.23

0.18

1.5

1.7

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

435

0.92

0.18

1.5

—

(4212803)

1.15

0.17

1.1

1.0

—

(44806071)

1.13

0.17

1.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.72

0.16

4.2

2.9

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.72

0.16

8.4

5.8

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

167

1.14

0.16

1.0

1.1

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

1.18

0.16

1.0

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.14

0.16

1.0

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.13

0.16

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

642

1.06

0.15

1.0

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

168

1.13

0.15

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

159

1.13

0.15

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

159

1.13

0.15

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

159

1.13

0.15

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

159

1.13

0.15

1.0

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.08

0.14

1.0

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

169

1.12

0.14

1.7

1.9

—

(4146454)

703

1.05

0.14

2.4

2.6

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

285

0.91

0.14

3.9

5.2

25.0

236.5

u/ml

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

160

1.12

0.14

1.7

1.2

26.6

33.9

0.39

104

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

363

1.07

0.13

1.1

272.5

314.0

mg/l

0.78

309

(3015183) Erythrocyte sedimentation rate

199

1.11

0.13

1.0

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

403

1.07

0.13

1.1

1.0

0.1

0.3

u/ml

—

100

(3047352) Trisomy 18 risk [Likelihood] in Fetus

333

0.93

0.11

1.5

1.4

—

(3003740) Influenza virus B Ag [Presence] in Specimen

640

1.05

0.11

1.0

1.1

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

192

1.09

0.10

5.4

4.4

69.7

71.7

0.18

157

(3005033) Fetal Nuchal fold Thickness US

331

0.94

0.10

1.5

1.4

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

125

1.12

0.10

1.2

1.3

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.14

0.10

1.0

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.04

0.09

1.0

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.80

0.07

1.0

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

727

1.03

0.07

1.1

0.8

1.4

u/ml

0.84

293

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

112

0.89

0.07

1.0

1.2

—

(40758292) HTLV I+II Ab panel - Serum

1.06

0.07

1.3

1.5

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

0.88

0.06

1.0

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.12

0.06

1.0

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

344

0.96

0.05

1.5

—

(4094501)

156

1580

0.99

0.04

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

488

1.02

0.03

1.0

1.1

2.9

3.5

u/ml

0.12

194

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

260

1.04

0.03

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

847

1.01

0.03

1.1

22.1

1072.0

iu/ml

0.94

201

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

450

1.02

0.02

1.0

282.5

325.5

ng/l

0.83

310

(3023430) Cat dander IgE Ab [Units/volume] in Serum

442

1.02

0.01

1.0

1.1

4.2

3.1

u/ml

0.13

178

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

452

1.02

0.01

1.0

35.4

45.1

ng/l

1.15

304

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

108

1.02

0.00

1.4

2.9

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

225

1.02

0.00

1.1

1.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

398

1.00

0.00

1.2

1.3

98.7

141.8

pmol/l

0.23

121

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

122

0.98

0.00

1.0

1.3

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

451

1.00

0.00

1.0

695.8

695.5

ng/l

0.00

297

(3010726) Horse dander IgE Ab [Units/volume] in Serum

570

1.00

0.00

1.1

4.2

2.1

u/ml

0.23

138

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

385

1.01

0.00

1.2

41.2

46.0

mg/l

0.37

312

(40768793) Breast Pathology biopsy report

123

1224

1.00

0.00

1.2

1.3

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

0.0

1.0

—

172.3

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

0.00

0.0

1.1

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.0

1.0

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.00

0.00

1.0

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.0

1.6

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.4

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.0

1.0

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

0.0

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.1

—

1400.0

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

137.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

0.90

0.00

1.0

1.3

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.0

1.0

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

0.0

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3022670) pH of Venous cord blood

0.00

0.0

1.0

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

6.8

—

0.2

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

31.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

0.90

0.00

1.0

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

0.90

0.00

1.0

1.3

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

0.0

1.0

—

0.5

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint K11_OTHILEUS and mortality.

Females

Parameter	HR [95% CI]	p-value
K11_OTHILEUS	2.598 [2.35, 2.87]	< 0.001
Birth year	0.997 [0.99, 1.0]	0.489

During the follow-up period (1.1.1998 — 31.12.2019), 12605 out of 24341 females with K11_OTHILEUS died.

Males

Parameter	HR [95% CI]	p-value
K11_OTHILEUS	2.576 [2.31, 2.87]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.003

During the follow-up period (1.1.1998 — 31.12.2019), 11756 out of 23689 males with K11_OTHILEUS died.

Mortality risk

Mortality risk for people of age

years, who have K11_OTHILEUS.

N-year risk	Females	Males
1	0.238%	0.443%
5	1.486%	2.437%
10	4.369%	6.074%
15	7.892%	12.221%
20	13.355%	20.602%

Relationships between endpoints

↥

Index endpoint: K11_OTHILEUS – Other or unspecified ileus, impaction or obstruction

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other or unspecified ileus, impaction or obstruction

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints